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Abstract 
 
First mark of atherosclerosis is linked to endothelial dysfunction, with a massive 
injury of endothelium of the vascular intima of blood vessels.  
Mechanical forces, as blood associated shear stress, play an important role in 
cardiovascular physiology. Atherosclerotic lesions can be detected in regions of low 
shear stress (LSS) and disturbed blood flow at curvatures and narrows of vessels 
and capillaries.  
 
Various diseases such as diabetes, chronic renal insufficiency, and obesity come 
along with elevated levels of blood cholesterol and different modified low-density-
lipoproteins (LDL). The modification of lipoproteins is a key event in early 
atherosclerosis, which leads to endothelial dysfunction and the formation of foam 
cells. 
Human coronary artery endothelial cells (HCAEC) are used for studies of 
atherosclerosis, to observe the effect of modified LDL, such as oxidized, 
carbamylated, and glycated LDL. High-density-lipoprotein (HDL) and also the female 
hormone estrogen are defined to be vasoprotective and antagonize the formation of 
atherosclerotic lesions. 
Lipotoxicity on endothelial cells could be demonstrated with increasing concentration 
of different modified LDL. We could determine that estrogen and HDL lower the 
cytotoxic effect of modified LDL on endothelial cells in cell culture experiments. 
 
Previous data focused on the regulation of inflammatory sensors and upregulation of 
scavenger receptors. In this study the question was addressed to determine the role 
of LDL receptor gene family members, such as LDL receptor, LRP1 and LRP2 in 
HCAEC and the impact of modified LDL. More interest was also raised in sex specific 
differences and the impact of estrogen 17-beta estradiol (E2) in vasculature. The 
investigation was based on incubation of HCAEC with different modified LDL under 
static cell culture condition and also under subjection to shear stress. The Fiber 
Cell™ module is designed for cell culture experiments to study endothelial cells 
under shear stress. 
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However, LDL receptor expression seemed to be downregulated on the transcript 
level after exposure of endothelial cells to modified LDL under static conditions and 
under LSS. HSS affects the activation of LDLR in vasculature. Hence, LRP2 could be 
detected at low-level expression on the mRNA level in both conditions. LRP1 could 
not be detected under static conditions, but a slight upregulation under shear stress 
could be detected. 
Moreover, estrogen induced a slight upregulation of the mRNA level of LRP1 and 
LRP2 under static conditions. The LDL receptor seemed to be significantly 
upregulated by estrogen administration, also published by Smith et al, 2004. 
Concluding, the vasoprotective effect of estrogen and HDL and the lower incidence 
of toxic effects of modified LDL on HCAEC could be shown. The expression of LDL 
receptor gene family members, including LDLR, LRP1, and LRP2 seemed to be 
downregulated in atherosclerotic events. 
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Zusammenfassung 
 
Erste Anzeichen der Atherosklerose kennzeichnen sich durch die endotheliale 
Dysfunktion in Folge von massiver Schädigung des Endothels in der Intima der 
Blutgefäße. 
Der Blutfluss und die dabei wirkenden mechanischen Scherkräfte spielen eine 
entscheidende Rolle in der Gefäßhomeostase und der Aufrechterhaltung der 
Endothelfunktion. An Abgängen, Verzweigungen und Verengungen von Blutgefäßen 
wirken geringere Scherkräfte und der Blutfluss verlangsamt sich, infolgedessen 
treten an diesen Stellen vermehrt atherosklerotische Plauqes auf. 
 
Verschiedene Krankheiten wie Diabetes, chronische Niereninsuffizienz und 
Übergewicht gehen mit erhöhtem Blutcholesterolspiegel einher. Patienten haben 
durch die Krankheit vermehrt modifizierte Lipoproteine im Blut. 
Modifikationsprozesse von LDL stehen mit ersten Anzeichen der Atherosklerose in 
Verbindung. 
Humane koronare arterielle Endothelzellen (HCAEC) werden häufig im 
Forschungsbereich der Atherosklerose, insbesondere der endothelialen Dysfunktion 
eingesetzt, um die Wirkung von modifizierten LDLs und die dabei resultierende 
Schädigung der Endothelzellen herauszufinden. 
HDL und das weibliche Hormon Östrogen wirken Schädigungen entgegen und 
werden als vasoprotektiv beschrieben. 
 
Anhand von Toxizitätstests konnte die Lipotoxizität mit steigender Konzentration an 
modifizierten LDL auf Endothelzellen gezeigt werden. Die Vermutung konnte 
bekräftigt werden, dass HDL und 17-beta Estradiol (E2) den toxischen Effekt in 
Zellkulturexperimenten vermindern konnten. 
Frühere Studien befassten sich mit der Regulation von inflammatorischen Markern 
und der Regulierung von Scavenger Rezeptoren, den sogenannten Fressrezeptoren. 
Bisher ist wenig über die Regulation von LDL Rezeptor Familienmitgliedern im 
vaskulären Endothelium bekannt. 
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Das Ziel meiner Diplomarbeit war, die Rolle von LDL Rezeptor Familienmitgliedern, 
wie LDL Rezeptor, LRP1 und LRP2, in diesem Zusammenhang zu definieren. 
Hierbei sollten HCAEC mit verschiedenen modifizierten LDLs (oxidiertem, glykiertem 
und carbamyliertem LDL) behandelt werden. Weiters sollten geschlechtsspezifische 
Unterschiede erfasst werden, indem Zellen zusätzlich zu modifizierten LDL mit E2 
behandelt wurden.  
Die Expressionsanalysen wurden unter statischen Bedingungen und unter 
Einwirkung von Scherkräften in Zellkartuschen (Fiber Cell™ Model) durchgeführt.  
 
Zusammenfassend konnte gezeigt werden, dass der Transkriptionslevel von LDL 
Rezeptoren unter statischen Bedingungen und unter geringen Scherkräften 
verringert wird. Erhöhter Blutfluss und Scherkräfte wirken aktiv auf Rezeptoren der 
Endothelzellen. LRP2 mRNA konnte nur mit geringem Expressionstatus 
nachgewiesen werden. LRP1 konnte auf Transkriptionsebene in 
Zellkulturexperimenten nicht nachgewiesen werden, aber eine basale Aktivierung 
unter Einfluss von Scherkräften. 
In Zellkulturexperimenten zeigte die Inkubation von Endothelzellen mit E2 und 
modifizierten LDL, einen geringen Antsieg von LRP1 und LRP2 auf mRNA Ebene. 
Eine signifikante Steigerung der LDL Rezeptor mRNA-Expression konnte bei E2 
Zugabe erkannt werden. 
Generell scheint die mRNA-Expression von LDL Rezeptor Familienmitgliedern unter 
Einwirkung von modifizierten LDLs in frühen atherosklerotischen Stadien verringert 
zu werden. 
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Chapter 1 
 
Introduction 
 
 
1.1 Cardiovascular disease and atherosclerosis 
 
1.1.1 Cardiovascular disease (CVD) 
 
The atherosclerotic cardiovascular disease accounts 2 million deaths per year in the 
European Union (EU) [Ref 1]. 
The traditional cardiovascular risk factors, defined by epidemiological studies such as 
the Framingham study, are high blood pressure, diabetes mellitus, dyslipidemia, 
male sex, smoking, and obesity. Patients with kidney disease as chronic renal 
insufficiency have an increased risk to develop atherosclerotic plaques 
[Longenecker, 2002]. 
The secondary effect of disease state is the disturbed lipoprotein metabolism. The 
initiating factor is the elevated level of blood cholesterol with high amounts of 
modified low-density-lipoproteins (LDL), which are associated with atherosclerotic 
plaque formation.  
Atherosclerosis, and at least CVD syndromes, can also be caused by inherited 
genetic variances in family history with premature CVD. 
Overall, several diseases and genetic variabilities are the main contributors for the 
development of cardiovascular pathologies. However, lifestyle, aerobic exercise, and 
body weight play an important role for health. Sports and a normal body mass index 
(BMI) can lower the incidence of CVD. 
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1.1.2 Atherosclerosis 
 
Atherosclerosis is a severe disease substituted into different stages from early 
lesions to advanced plaque progression. 
End stage atherosclerosis in coronary arteries contributes to development of CVD, 
including myocardial infarction and stroke. Considering this, atherosclerosis was also 
defined as an inflammatory disease [Ross, 1999]. 
As mentioned before, people who suffer from diabetes or patients with kidney 
disease have a higher incidence of developing atherosclerosis. Also obesity, 
smoking, and hypertension are associated with occurence of atherosclerotic lesions. 
Atherosclerosis is a disease initiated by insults to the endothelium in the vasculature. 
Endothelial dysfunction is described as an early marker and precedes the 
progression of atherosclerotic plaques [Hadi, 2007]. 
The main risk factor is the elevated cholesterol level and the accumulation of lipids in 
the subendothelial region of the arterial wall. Native and modified LDLs contribute 
mainly to atherothrombosis [Llorente-Cortes, 2005; Llorente-Cortes and Estruch, 
2010; Badimon, 2009]. These LDL particles are retained in the subendothelial wall 
because of reduced turn-over and prolonged residence time, leading to modification 
of LDL. In further states of atherosclerosis, native LDL and also modified LDL can 
migrate through endothelial junctions into the vascular intima and further into the 
vascular media. The transcytosis of LDL leads to interactions with extracellular matrix 
(ECM) components such as proteoglycans, collagen, as well as elastin [Schwandt & 
Parhofer]. There, LDL can undergo modification processes through ECM residing 
proteolytic enzymes and oxidants (lipoxygenase, myeloperoxidase, free radicals) 
[Llorente-Cortes, 2005; Badimon, 2009]. LDL can be retained there for hours or days. 
LDL not only influences endothelial properties, but also modifies antithrombotic 
activities in the endothelium.  
The first step starts with impaired function of the endothelium and comes along with 
inflammation and production of free radicals leading to massive endothelial cell 
damage by oxidative stress. The injury and dysfunction of the endothelium turns on 
remodelling processes for proliferation and migration of smooth muscle cells, which 
thicken the arterial walls. Inflammation causes harmful oxidative stress in vessel wall 
through defense mechanisms, such as producing hydrogenperoxide (H2O2) and 
   7 
reactive oxygen radicals [Ross, 1999; Badimon, 2009]. Inflammatory response is 
potentiated by disturbed gene expression in endothelial cells and the mobilization of 
more inflammatory cells to the lesion site. Modified LDLs are chemotactic and can 
up-regulate the expression of genes for the macrophage colony stimulating factor 
and for the monocyte chemotactic protein derived from endothelial cells  [Ross, 
1999]. Macrophages and lymphocytes emigrate and their activation leads to the 
release of more hydrolytic enzymes, cytokines, chemokines, and growth factors 
[Ross, 1999]. Monocytes derived macrophages bind modified lipoproteins to their 
scavenger receptor and accumulate lipids. Accumulation of cholesterol esters results 
in the formation of foam cells (Fig.1.1).  
 
 
Fig.1.1 Several stages of atherosclerosis from transcytosis of LDL and the 
modification, to emigration of monocytes and the formation of foam cells in the 
endothelium of the vasculature [Ref 2]. 
 
Foam cells increase the vulnerability of the atherosclerotic plaque [Llorente-Cortes, 
2005; Badimon, 2009]. Overload of foam cells can lead to necrotic processes.  
Building of foam cells is restricted to macrophages and also smooth muscle cells. 
Endothelial cells do not undergo foam cell formation and do not accumulate 
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cholesterol in plaques as macrophages and smooth muscle cells [Hassan, 2006]. 
They avoid the uptake and the accumulation of cholesterol intracellularly and are 
able to shut down the cholesterol synthesis and the further uptake of endogenous 
cholesterol.  
An advanced complicated lesion is build by enlargement of fibrous tissue and 
formation of a fibrous cap that overlies the core of lipids [Ross, 1999; Badimon, 
2009]. Arteries can no longer compensate by dilation, lesions intrude into lumen and 
alter the blood flow [Ross, 1999]. 
 
 
 
 
Fig.1.2 Atherosclerotic pathologies on aorta [Ref 3] 
 
At end stage of atherosclerosis the blood vessel diameter decreases dramatically. 
Plaque rupture and thrombosis lead to complications, such as myocardial infarction 
and acute coronary syndromes (Fig.1.2) [Ross, 1999]. 
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Fig.1.3 Plaque rupture [Ref 4] 
 
 
1.2 Endothelium and endothelial dysfunction 
 
1.2.1 Structure of endothelium 
 
The vascular bed in coronary arteries is structured in three different layers, including 
the Tunica interna (Intima), Tunica media (Media), and Tunica externa (Adventitia) 
[4]. 
The endothelium is constituted of a monolayer of endothelial cells in tight connection 
to a large layer of smooth muscle cells (SMC) and an extracellular matrix (ECM) 
seen in Fig.1.3.  
 
 
 
Fig.1.4 Structure of vasculature [Ref 5] 
 
Permeability of endothelial cells is regulated by gap junctions and tight junctions, the 
so called functional connexins.  
The tunica media, build up of smooth muscle cells, is responsible for the production 
of extracellular matrix components and diverse regulatory processes. 
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Endothelial cells act mainly as a barrier between blood and vessel wall. These cells 
react towards stimulation by blood flow, by activation of signalling pathways, and by 
the regulation of the tonus, coagulation, and proliferation of smooth muscle cells. 
Endothelial cells control the vascular homeostasis and the balance between 
vasodilation and vasoconstriction. When the balance is upset, endothelial dysfunction 
occurs causing damage of arterial walls and activation of pathological processes, 
which lead to plaque formation [Davignon, 2004]. 
 
 
1.2.2 Endothelial function 
 
The activation of endothelial cells induces the production of endothelial derived 
regulating factors for vasodilation and vasoconstriction. 
A major vasodilative substance released by the endothelium is nitric oxide (NO), 
originally identified as the endothelium derived relaxing factor (EDRF) [Schwandt & 
Parhofer; Vance & Vance]. Other vasodilators including prostacyclin and brandykinin 
stimulate the release of NO and inhibit platelet aggregation [Davignon, 2004]. 
NO is synthesized from L-arginin by endothelial nitric oxide synthase (NOS) by the 
formation of L-citrulline and NO in vasculature.  
Three isoforms of NOS are defined, such as the two constitutive forms NOS-I or 
neuronal (nNOS), NOS-III or endothelial (eNOS), and the inducible form NOS-II 
(iNOS) [Kublickiene, 2008]. The constitutively expressed NOS requires 
calcium/calmodulin for activation, whereas iNOS gets activated by cytokines and 
inflammatory markers. Co-activators like tetrahydrobiopterin, nicotinamide-adenin-
dinucleotidephosphate (NADPH), and coenzyme as calmodulin are involved in the 
production of NO (Fig.1.4) [Davignon, 2004; Hirata, 1995]. 
NO acts on guanylyl cyclase of SMC, to release cGMP following the activation of 
protein kinase G, which leads to a reduced calcium concentration. Reduction of the 
calcium release causes relaxation of SMC [Schwandt & Parhofer]. 
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Fig.1.5 Endothelial function and the production of nitric oxide (NO) [Ref 6] 
NO is not only anti-inflammatory and inhibits the adhesion of monocytes, it also 
controls the production of reactive oxygen species (ROS), platelet aggregation, and 
sustains the endothelium against lipoprotein permeability. 
Vasoconstrictors in vascular system are endothelin, described as the most potent 
constrictor, and angiotensin II. Angiotensin II mainly activates the growth of SMC 
[Sendra, 2008]. 
 
 
1.2.3 Endothelial dysfunction 
 
Imbalance of vasodilation and vasoconstriction to impaired vascular relaxing are 
early signs of endothelial dysfunction. The first step of development of 
atherosclerosis is the injury of the endothelium in coronary arteries. 
As mentioned before, the progression of plaque formation comes from subendothelial 
retention of modified LDL particles and oxidative stress. Oxidative stress results in 
inflammatory response and migration of macrophages to the subendothelial region. 
Retaining native and modified LDL reduces the activation of NO synthase. 
Furthermore, NO can be faster degraded because of redox imbalance [Llorente-
Cortes, 2005; Llorente-Cortes and Estruch, 2010]. Cell damage results in a reduced 
NO bioavailability, and comes along with the release of vasoconstrictive endothelin, 
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the aggregation of platelets and the expression of adhesive molecules. Meanwhile 
monocytes adhere to endothelial cells [Hirata, 1995]. 
During normal aging processes, the vasculature is also subjected to remodelling 
processes and a change in vessel diameter can be detected, correlating with higher 
blood pressure [Hirata, 1995]. 
Vascular aging shows an impaired endothelial mediated vasodilation and an 
overgrowth of smooth muscle cells causing atherosclerotic lesions. These factors 
increase the risk of cardiovascular events. 
 
 
1.3 Lipoproteins 
 
1.3.1 Low-density-lipoprotein (LDL) 
 
 
 
Fig.1.6 Basic structure and composition of LDL [Ref 7] 
 
Lipids are water insoluble molecules with a highly hydrophobic nature and can 
therefore only be transported in circulation via lipoproteins. Plasma lipoproteins can 
vary in size, composition, and their different functions in lipid metabolism. 
Lipoproteins are spherical molecules with approximately 10-1200 nm diameter and 
show a density between 1.019 and 1.063 g/ml [Willnow, 2007; Llorente-Cortes, 
2005]. Lipoprotein particles are build up by an amphiphatic shell of polar 
phospholipids and cholesterol, the inner core is filled with neutral lipids like 
cholesterolesters, triglycerides, and fat soluble vitamins. Apolipoproteins reside in the 
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shell of lipoproteins, which are important for assembly and the recognition by LDL 
receptors. The exclusive apolipoprotein of LDL is apoB 100, which is able to bind to 
LDL receptor binding domains. ApoB 100 facilitates the uptake and catabolism of 
LDL. 
The lipid cargo is delivered by receptor-mediated endocytosis of LDL receptor gene 
family members. The apolipoprotein moiety is degraded into small peptides and the 
lipids are released intracellularly [Goldstein et al, 2001]. 
  
 
 
Fig.1.7 Concept of the LDL receptor mediated endocytosis [Willnow, 2007] 
 
 
1.3.2 Modification of LDL 
 
LDL does not only occur in its native form, but also in different modifications, such as 
lipid oxidized LDL, hypochlorite (HOCl) modified LDL from the myeloperoxidase-H2O2 
halide system, glycated LDL and, carbamylated LDL. These modifications are 
thought to be even more proatherogenic.  
Lipoproteins, which are retained in the subendothelial layer for a prolonged time, are 
susceptible for modification. Several types of modified LDLs can circulate in blood, 
also in a healthy person. Modifications occur spontaneously by nonenzymatic 
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reactions. Normally, they are recognized and eliminated without any atherogenic 
effect. 
In patients the situation of modification is more problematic, because modified LDL 
cannot be cleared properly. 
 
 
1.3.2.1 Oxidation of LDL 
 
Oxidation occurs as a normal event in humans, through oxidants in blood circulation. 
LDL and also HDL are subjected to oxidation, which can cause pathologies.  
Studies revealed that in minimally oxidative LDL, the apoB 100 has oxidized amino 
groups [Himmelfarb, 2002].  
Oxidants are highly reactive compounds with a half life of seconds, but nevertheless 
lipids, which are oxidized by oxy-radicals have lifetimes ranging from hours to weeks 
[Locatelli, 2003]. Both H2O2 and oxygen (O2) are potential precursors for the 
production of powerful oxidants [Locatelli, 2003]. O2 is able to interact with NO in 
endothelial cells to form high reactive nitrogen species, while H2O2 produces hydroxyl 
radicals (OH-) with intracellular iron, leading to lipid degradation in cell membranes 
[Locatelli, 2003]. 
Reactive aldehyds can be formed by oxidation of alcohol groups and via the addition 
of oxygen to unsaturated carbon double bonds in carbohydrates, lipids or amino 
acids [Himmelfarb, 2002]. Oxidized LDL (oxLDL) raises the production of reactive 
oxygen species (ROS), which can lead to endothelial dysfunction [Thum, 2007].  
Oxidation is a potential source of atherosclerosis, because individuals are subjected 
to enhanced oxidative stress, but reduced anti-oxidant systems such as vitamin C, 
reduced vitamin E content, and decreased activity of the glutathione system 
[Locatelli, 2003]. OxLDL cholesterol inhibits the first step of production of NO by 
eNOS. Circulating oxLDL gets caught by scavenger receptors of macrophages and 
thereby modulates the remodelling of the vessel wall. Endothelial cell injury is 
accelerated and proliferation of smooth muscle cells is induced. 
Even so, oxidative stress occurs in healthy individuals, it plays an important role in 
host defense mechanisms, but is excessively activated in pathological conditions.  
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1.3.2.2 Kidney disease and modification of LDL 
 
Different diseases contribute to the genesis of atherosclerotic lesions in coronary 
arteries. 
Chronic kidney disease in humans is associated with an increased risk factor for 
development of CVD. Dialysis patients represent the most relevant risk group 
regarding carbamylated LDL, since either the reduced renal clearance or the critical 
production of modified LDL. Thus, patients have a high concentration of LDL and 
moreover excessive urea remaining in the blood circulation with a long residence 
time. Carbamylation of LDL is generated by a nonenzymatic reaction of cyanate 
derived from urea. The active form, isocyanic acid, reacts with free nonprotonated 
amino groups of proteins [Ok, 2005]. Carbamylation results in neutralization of 
positive charges of modified lysine residues [Ok, 2005]. Carbamylated LDL induces 
dose dependent vascular cell injuries relevant to atherosclerosis and is the most 
abundant modified protein in human blood. The mortality in patients with advanced 
kidney disease is 10 to 20 times higher than in the general population [Ok, 2005]. 
 
 
1.3.2.3 Diabetes and modification of LDL 
 
Diabetes is denoted by a high concentration of glucose in blood. Insulin resistance is 
associated to blocked uptake of glucose in muscle and therefore remaining in blood 
circulation. 
High glucose concentration is assumed to be the key factor for autooxidation. 
Glucose is able to bind non-enzymatically to free amino groups on proteins or to 
lipids [DeVriese et al, 2000]. Hyperglycemia activates the modification of plasma 
proteins like LDL, but also other tissue proteins can be modified by glycation. Small 
dense subfraction LDL3 is more susceptible to glycation in the apoB molecule, even 
in non-diabetic individuals [Younis, 2009]. Glycation products are called advanced 
glycation end products (AGE). AGE are irreversibly formed and accumulate in the 
region of atherosclerotic plaques [Toma, 2009]. AGE are known to quench the NO 
activity and impair endothelial function. Besides, also in diabetic patients an elevated 
level of oxidized LDL can be detected, the mixture of glycated and oxidized LDL 
amplifies the formation of lesions in vasculature. Glyoxidized LDL is known as 
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advanced lipid oxidation end product (ALE) [Younis, 2009; Locatelli, 2003]. Thus 
modified LDL has a slower catabolic rate than native LDL [Younis, 2009].  
AGE and ALE can directly affect vasculature by oxidant and inflammatory response 
in endothelial cells [Toma, 2009]. AGE bind to specific cell receptors (RAGE), which 
in turn trigger oxidative stress and inflammatory responses.  
Nevertheless, glycated LDL also accumulate in normal human body with age, but 
individuals with diabetes have high amounts of AGE molecules in their circulation. 
 
 
1.3.3  High-density-lipoprotein (HDL) 
 
 
Fig.1.8 Basic structure and composition of HDL [Ref 8] 
 
High-density-lipoprotein mediates the cholesterol efflux from peripheral cells via 
apoA-I and the reverse cholesterol transport to the liver [Schwandt & Parhofer]. The 
reverse cholesterol transport acts by clearing lipids from vessels and impairs the 
formation of atherosclerotic plaque [Willnow, 2007].  
HDL is known as an anti-inflammatory and antioxidant particle, which can influence 
the development of cardiovascular disease and atherosclerosis.  
 
 
1.3.3.1 Protective function of HDL in cardiovasculature 
 
Many studies discovered the positive impact of HDL on atherosclerosis. HDL is 
considered as an antiatherogenic molecule because its protection of endothelial 
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cells. HDL protects against oxidative imbalance including modification of LDL 
particles in subendothelial regions. 
Overall the major components of HDL molecules, which are apoplipoproteins, 
enzymes and sphingosine-1-phosphate (S1P) can influence the pathologies in the 
cardiovascular system. HDL associated S1P mediates the function of endothelial 
cells such as migration, proliferation, and endothelial integrity [Podrez, 2010]. 
Furthermore, the apoA-I part on HDL plays an antiatherogenic and antioxidant role, 
because it can remove oxidized phospholipids from oxidized LDL [Podrez, 2010; 
Ren, 2000]. HDL has the property to inhibit oxidative processes; HDL3 has the most 
potent antioxidant activity [Podrez, 2010]. 
But overall, a reduced level of plasma HDL can be detected in disease state and 
correlates with increased catabolism of HDL. 
 
 
1.4 LDL receptor gene family members 
 
1.4.1 Overview 
 
The low-density-lipoprotein receptor gene family constitutes of several structurally 
closely related cell surface receptors including LDLR, VLDLR, LRP1, LRP1b, LRP2, 
MEGF7/LRP4, and LRP8/apolipoprotein E receptor 2 (APOER2). They fullfil distinct 
biological functions in different organs, tissues, and cell types [Goldstein et al, 2001; 
Fisher, 2006]. 
 
The main function of these family members is the regulation of lipid metabolism. 
They are also involved in transport of nutrients, especially vitamins, and in neuronal 
development. Additional functions are described, for example in signal transduction 
during embryogenesis by transmitting signal molecules to target tissue [Schneider, 
2003]. 
All family members share sequence homologies and are build of similar motifs for 
various functions. They consist of a large extracellular domain with cystein rich motifs 
for ligand binding and epidermal growth factor like repeats (EGF). An O- linked sugar 
domain is connected to the transmembrane domain. The intracellular domain has the 
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important YWTD (Tyr-Trp-Thr-Asp) motiv for pH-dependent release of ligands in 
endosomes. LDL receptor family members are clustered at sides of clathrin-coated 
pits on the cellular membrane by their NPXY (Asn-Pro-Xxx-Tyr) motifs [Willnow, 
2007; Fisher, 2006; Schneider 1998]. 
 
Dysfunction of LDL receptor gene family members can be connected to diverse 
developmental defects.  
 
 
 
 
Fig.1.9 Overview of the LDL receptor gene family members. More distantly 
related members include LRP-5, LRP-6, and SorLA, which are characterized 
by unique combinations of domains [Willnow, 2007]. 
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1.4.2 Low-density-lipoprotein receptor (LDLR) 
 
Low-density-lipoprotein receptor was the first discovered receptor of the LDL receptor 
gene family [Schneider, 1989]. 
Familial hypercholesterolemia (FH) is caused by LDLR gene defects. People with FH 
have problems with the clearance of cholesterol rich LDL, leading to excessive levels 
of LDL in the blood [Goldstein, 2001].  
The LDLR is involved in endocytosis of cholesterol-laden lipoproteins at clathrin-
coated pits and binds the apolipoproteins apoE and apoB 100 on the cell surface of 
the lipoprotein shell. The human LDLR is approximately 160 kDa in size, but size 
depends on glycosylation status. The precursor protein is synthesized with a 
molecular weight of 120 kDa that is subsequently glycosylated to the mature form by 
N- and O-linked glycosylation. 
Approximately 70% of LDL receptors in humans are expressed on liver cells [Mehta, 
1999]. The transcription of LDL receptor is under tight control by ER associated 
sterol-responsive-element-binding-protein (SREBP). When sterols accumulate 
intracellularly, the synthesis of the receptor is repressed. In contrast, transcription of 
LDL receptor is induced when cells need increased demands of cholesterol [Mehta, 
1999]. A decrease in LDL receptor on plasma membrane leads to accumulation of 
extracellular LDL in circulation. 
 
 
1.4.3 Low-density-lipoprotein receptor related protein 1 (LRP1) 
 
LRP1 is a large molecule composed of two subunits, a 515 kDa !-chain at the N-
terminus and a smaller 85 kDa "-chain at the C-terminus of the protein.  
The receptor plays a role in a variety of biological processes, including lipoprotein 
metabolism, protease degradation, activation of lysosomal enzymes, endocytosis of 
bacterial toxins, and viruses [Zhou, 2009]. 
LRP1 is widely expressed in distinct tissues and different cell types. It controls the 
clearance of dietary lipids in the liver [Willnow, 2007], but is not regulated by 
intracellular cholesterol. Lipoprotein remnants containing apoE are recognized and 
bound by LRP1 on the cell surface [Llorente-Cortés, 2004; Lilis, 2008]. LRP1 is 
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abundantly expressed in the vascular wall, in vascular smooth muscle cells (VSMCs), 
and macrophages. Patients suffering from coronary heart disease show an alteration 
in LRP1 gene expression.  
Deficiency in LRP1 gene expression causes lethality in embryogenesis around mid-
gestation and impaired function of the liver [Willnow, 2007; Hammes, 2006]. 
 
 
1.4.4 Low-density-lipoprotein receptor related protein 2 (LRP2) 
 
LRP2 (Megalin/gp 330) is a transmembrane receptor, a type I cell surface receptor. 
This receptor is one of the largest LDLR family members with a molecular weight of 
517 kDa in the non-glycosylated form.  
 
The expression of LRP2 is distributed to distinct tissues, forming the apical epithelial 
cell borders. Main organs of expression include the yolk sac and the neuroepithelium 
of embryos, the proximal renal tubules, and the small intestine in adult organisms 
[Christensen & Birn, 2001]. 
LRP2, a multiligand binding receptor with scavenger function, regulates lipoprotein 
metabolism by binding LDL, filtrates vital substances from urine in the renal proximal 
tubules, is regulating the vitamin D homeostasis, and is essential as a messenger in 
certain organ systems during embryogenesis and brain development. 
Another function is the response and binding of sex steroids in reproductive organs. 
Androgens and estrogens are bound and regulated by sex hormone binding globulin  
(SHGB). LRP2 mediates the endocytosis of SHGB into reproductive tissue, which 
has already been described in a mouse model [Hammes, 2005].  
 
LRP2-deficient mouse embryos show to developmental defects, including 
malformation of reproductive organs and forebrain development [Willnow, 2007; 
Hammes, 2005]. 
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1.4.5 Receptor associated protein (RAP) 
 
Receptor associated protein acts as chaperon for LDLR family members, with 39 kDa 
in size. It binds LDLR- family members in the endoplasmatic reticulum (ER) for 
folding processes of these receptors and proper assessement to secretory pathways 
[Christensen & Birn, 2001]. RAP is associated to the ER by a carboxy-terminal 
tetrapeptide (HNEL), which is similar to ER-retention consensus sequence (KDEL) 
[Bu and Marzolo, 2000]. The expression is distributed to different tissues with the 
highest expression in kidney and brain. Bu and Marzolo described a model of how 
RAP functions as chaperon for LDL receptor family members. RAP associates with 
newly synthesized receptors and prevents the premature interaction of these 
receptors with ligands. During the secretory pathway and the maturing process, RAP 
dissociates in medial-Golgi from receptors because of low pH. A retrieval pathway 
transports RAP back to the ER compartment. 
 
 
1.4.6  Scavenger receptors 
 
Native LDL particles are normally internalized by binding to LDL receptors on cell 
membrane in clathrin-coated pits. In contrast, special scavenger receptors recognize 
aggregated modified LDLs and clear them from circulation. Such scavenger 
receptors are mainly expressed on macrophages, but could also be detected in 
SMCs and on platelets [Badimon, 2009]. The internalization of modified LDL is 
controlled by these scavenger receptors: SR-AI and SR-AII, CD36, LOX-1 or 
CXCL16 [Moore, 2006]. Endothelial cells express receptors specialized for uptake of 
oxidized LDL, such as CD36 transmembrane receptor [Carvalho, 2010]. 
In vasculature, modified LDL are also recognized and internalized by LRP1, 
especially in SMCs. LRP1 expression increases with higher accumulation of 
cholesterol-LDL in the intima of vasculature.  
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1.5 Blood flow associated shear stress 
 
Endothelium in the cardiovasculature is subjected to chemical and mechanical 
stimulation; endothelial cells are continuously exposed to blood flow associated 
shear stress. The mechano-transduction working on endothelium, through 
mechanical force as shear stress, activates biochemical processes. The shear stress 
provides endothelial cell integrity and vascular function. Mechanical forces are 
vasoprotective and inhibit the apoptosis of endothelial cells. 
Blood shear stress has an important impact on endothelial structure and regulation. 
The hemodynamic shear stress conditions play a critical role in early atherosclerosis. 
Mainly two types of shear stress conditions exist in vascular wall, the protective 
laminar high shear stress and the atherogenic low, oscillatory shear stress (LSS). 
Regions of arterial narrowing, curvatures, and bifurcations are especially susceptible 
to atherosclerotic lesion formation, because these regions are subjected to low and 
oscillatory shear stress [Pan, 2009]. LDL preferentially accumulate in regions of 
oscillatory shear stress, at bifurcations, and curvatures of arteries. 
However, LSS tends to induce larger lesions with vulnerable plaque formation, 
whereas oscillatory shear stress tends to induce stable lesions [Pan, 2009]. At sides 
in vasculature were blood flows with high velocity meaning high shear stress (HSS), 
less formation of lesions is described by Pan, 2009. In contrast HSS or laminar blood 
flow preserves vascular homeostasis and the balance between vasodilation and 
vasoconstriction. HSS plays a key role in prevention of atherosclerosis.  
Endothelial cells are continuous subjected to shear stress in vivo. Upon exposure to 
laminar shear stress, endothelial cells are deformed by mechanical forces [Pan, 
2009]. 
The remodelling is important for transduction of signals. Changes in flow alter the 
expression of genes that have elements in their promoter regions that respond to 
shear stress. Some of these shear stress responding genes are: intercellular 
adhesion molecule 1, platelet derived growth factor B chain, and tissue factor in 
endothelial cells [Ross, 1999]. Thus, the expression is upregulated by reduced shear 
stress contributing to inflammation. Elevated levels of antiatherogenic eNOS are 
seen when blood flow is high. In addition increased NO release minimizes the 
permeability through endothelial tight junctions. Antiatherogenic molecule NO 
tightens the endothelial cell layer by sheer stress against the emigration of LDL and 
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macrophages. Depending on the kind of shear stress, different signalling pathways 
become activated and a various pattern in gene expression is induced. LSS 
promotes proatherosclerotic genes and HSS activates protective genes against 
atherosclerosis. 
Laminar shear stress, previously mentioned, upregulates the expression of 
vasoactive substances such as the endothelial NO synthase, prostacyclin and 
antioxidants.  
In contrast, LSS impairs the NO bioavailability, as well as increases the production of 
ROS and finally leads to endothelial dysfunction through apoptosis of endothelial 
cells [Pan, 2009]. 
Shear stress can be simulated and studied by the use of a chronic shear stress 
module. The Fiber Cell™ module is designed for cell culture experiments to study 
endothelial cells under subjection to shear stress conditions. 
This allows the study of endothelial cells in a more physiological environment, 
compared to cell culture under static conditions.  
 
 
 
Fig.1.10 Endothelial cell morphology under different hemodynamic shear 
stress conditions of 0.5 dyne/cm2 and high shear stress of 15 dyne/ cm2 [Pan, 
2009]. 
 
The cell morphology of a vasculature is imitated in a chronic shear module, as 
endothelium build up a monolayer and tight junctions are created. The cells can 
mimic their in vivo situation far better. It is known that gene expression pattern and 
protein expression profiles alter with various types of shear stress and can be 
different compared to static conditions. 
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1.6 Role of estrogen 
 
1.6.1 Overview of estrogen 
 
In recent years several studies demonstrated the effect of sex difference in diverse 
human physiological functions. Endothelium emphasizes the difference in gender in 
the cardiovascular physiology. Female sex is recognized as protective factor in 
cardiovascular disease and development of atherosclerosis. In younger age groups 
(25 to 49 years) coronary heart disease is two to five times more common in men 
than in women [Kublickiene, 2008]. Young men with a deficiency in the estrogen-
receptor ! show a higher incidence of atherogenic events at the age of 31 years 
[Kublickiene, 2008]. 
 
The first ovarian hormone estrone (E1) was isolated and its activity in biological 
samples was described in the early 1920 [Lieberman S, 2002]. 
Endogenous natural recycling estrogens are estrone (E1), estradiol (E2) and estriol 
(E3) [Smiley, 2009]. All steroid hormones are synthesized from cholesterol by 
steroidogenic enzymes residing in ER. E1 and E3 are formed in liver from E2. Half 
life of estrogen is about 3 hours, and it can be converted to the other forms E1 and 
E3 [Smiley, 2009]. 
     
 
Fig.1.11 Chemical structure of estradiol [Ref 9] 
Most steroids, like estrogen, are found in plasma bound to SHBG in a non-
stoichiometric manner, only 2-3% exist as unbound free physiological active 
molecules [Smiley, 2009]. Free estrogen can diffuse rapidly through free diffusion 
into cells, but SHBG bound estrogen binds to specific receptors on the cell surface. 
Steroids bound to SHBG are internalized by LRP2 embedded in clathrin-coated pits 
or other appropriate hormone receptors on the cell membrane. The “free hormone 
hypothesis” states the free entry of hormones by unspecific diffusion through the 
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plasma membrane. Steroids can traverse the plasma membrane by diffusion 
because of their small size and lipid solubility [Willnow, 2009]. 
Specific estrogen receptors (ER) are found intracellularly as nuclear receptors 
namely, ER! and ER", which can form homodimers or heterodimers [Smiley, 2009]. 
In endothelium, both receptors ER! and ER" are found. Endothelial injury results in a 
threefold upregulation of ER" and stable low–level ER! expression in vascular tunica 
media [Watanabe, 2001]. Coronary arteries have an abundant amount of ER". In 
vasculature a specific G-protein coupled receptor has been identified to respond 
rapidly to free estrogen. GPR39 is a structurally unrelated protein, which binds E2 
with high affinity and mediates G-protein signalling after estrogen binding [Smiley, 
2009]. It is not yet clear, if this GRP39 is an endoplasmatic associated receptor or 
expressed in the plasma membrane [Smiley, 2009]. 
Estrogen is the predominant sex hormone in women, affecting the development. It 
promotes the growth and differentiation of tissues, including adipose, nerve, and 
musculoskeletal tissue and the cardiovascular system [Smiley, 2009]. 
The estrogen amount is depending on the menstrual cycle and is also influenced by 
life style. In menopausal women, the estrogen level declines and as a result they are 
more susceptible to CVD. Life style, as cigarette smoke and, free radicals impair the 
positive effect of estrogen in women. Estrogen and estrogen receptor expression 
vary from person to person and a significant change arises through aging. 
Estrogen acts on vasculature, including endothelial cells, smooth muscle cells and 
also on extracellular matrix. Nevertheless, hormone replacement therapy is 
something controversial, because it seems to induce a progression of CVD and 
ischemic complications.  
 
 
1.6.2   Role of estrogen in endothelium 
 
It is known that the sex hormone estrogen has positive effects, for example in 
homeostasis of the endothelium in the cardiovascular region of the heart. Studies in 
animals and humans revealed the benefits of estrogen in cardiovasculature. In vivo 
studies on dogs and on isolated rat and rabbit hearts have shown, that estrogen 
treatment lowers the incidence of cardiovascular damage and enhances coronary 
blood flow [Smiley, 2009; Kublickiene, 2008]. 
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Estrogen is able to activate the expression of protective molecules in vasculature as 
vasodilatory nitric oxide and prostacyclin and reduces the effect of vasoconstrictors 
as angiotensin and endothelin. Estrogen provides the relaxation of smooth muscle 
cells by attenuation of endothelin release. Bioavailability of endothelial NO is greater 
in arteries of female compared to male and estrogen may mediate the gender 
difference in NO production [Smiley, 2009]. Estrogen interacts also with mitochondria 
and decreases the production of reactive molecules, such as superoxide 
[Kublickiene, 2008]. 
The aromatic ring of estrogen molecules, which is absent in progestines and 
androgens, may play a key role as antioxidant moiety [Kublickiene, 2008]. 
Estrogen has multiple vascular effects including alteration of lipid serum 
concentrations, coagulation, fibrinolysis, and the antioxidant properties [Smiley, 
2009]. The female hormone acts directly on endothelial cells. It activates 
angiogenesis and inhibits cell death. Furthermore, E2 stimulates the 
reendothelization in vascular healing [Billon, Lehoux, 2008]. Estrogen counteracts the 
negative correlations of atherosclerosis, such as vasoconstriction and oxidative 
stress.  
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Fig.1.12 Positive effects of estrogen the in female body [Ref 10] 
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Chapter 2 
 
Materials and Methods 
 
2.1 Materials 
 
Chemicals used for buffers and solutions were purchased from: AppliChem, BioRad, 
Fluka, GIBCO, Merck, Peqlab, Pierce, Qiagen, Roche, and Sigma-Aldrich. 
 
 
2.1.1 Cell culture 
 
Human coronary artery endothelial cells (HCAEC) were purchased from PromoCell 
and cultured as suggested by the supplier. Endothelial cell medium MV with growth 
supplement mix was also supplied by PromoCell. Cells were cultured in tissue culture 
flasks (25 cm2 and 75cm2) purchased from TPP and Nunc. For experiments cells 
were seeded in culture dishes (60.1 cm2  and 22.1 cm2) and on 96well cell-culture 
plates purchased from TPP and Iwaki. Cell culture cartridge was designed and 
delivered by FiberCell® Systems. 
 
 
 
 
 
 
 
 
 
 
 
   29 
2.1.2 Oligonucleotide primers 
 
The human oligonucleotides were synthesized by MWG-Eurofins. 
 
Name of human primers Sequence Tm (°C) 
Hu beta-actin_fw_16 5´ -GCGGGAAATCGTGCGTGACATT- 3´ 62 
Hu beta-actin_rev_17 5´ -GATGGAGTTGAAGGTAGTTTCGTG- 3´ 61 
LDLR_TMD1 5´ -GCTCACCACGGTGGAGATAGT- 3´ 61.8 
LDLR_TMD2 5´ -CARCGTGCTCCTCGTCTTCCTT- 3´ 62.1 
LRP1_fw_11 5´ -TGTCACCTCCAAGACAGTGCT- 3´ 59.8 
LRP1_rev_12 5´ -CGTTCCAAGCGGTAGACACTG- 3´ 61.8 
LRP2_fw_12 5´ -GCTGCAGAAAGTCTGGCTGTA- 3´ 59.8 
LRP2_rev_13 5´ -TACTCTCCCAATGTATGCGCGG- 3´ 62.1 
Table 2.1 Primers used for PCR 
 
2.1.3 Antibodies 
 
Human antibodies were purchased from Abcam, Calbiochem, and Sigma. A !-human 
LDLR polyclonal antibody was produced by our lab. 
 
Name Source Reference 
!-human LDLR rabbit Calbiochem 
!-human LRP1 rabbit Sigma 
!-human LRP2 rabbit Abcam 
!-actin rabbit Abcam 
!-rabbit- HRP 
conjungated 
goat polyclonal Sigma 
!-rabbit- HRP 
conjungated 
mouse polyclonal Sigma 
Table 2.2 Antibodies 
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2.2 Methods 
 
2.2.1 Cell culture 
 
Human coronary artery endothelial cells (HCAEC) were purchased from PromoCell 
and cultured as suggested by the supplier. 
HCAEC were grown in Endothelial Medium MV (PromoCell) with special growth 
supplement mix (applied with the medium) and 100 units/ml penicillin, 100 #g/ml 
streptomycin in a humidified incubator at 37°C and 5% CO2. Confluent cultures (70-
80%) were passaged by aspirating the medium and cells were washed gently with 
2ml PBS. Cells were detached with trypsin/EDTA. Detachment was controlled 
microscopically. To stop enzyme activity of trypsin solution, at least twice the volume 
of medium was added. Cells were centrifuged at 2 x g for 3 minutes (min) and the 
remaining pellet was resuspended in new medium. Cells were seeded on new culture 
flasks (T75) in an adequate splitting ratio of 1:3. 
 
 
2.2.2 Endothelial cell culture cartridges 
 
 
Fig.2.1 Cell cartridge [Ref 11] 
 
Endothelial cartridges were prepared in laminar flow hood by attaching 10 ml 
syringes to each of the ports A, B, C, D. The matrix of cartridge was activated with 20 
ml of 70% ethanol in syringe on port A, 3 way stopcock at positions B and C were 
closed. The halfe volume of ethanol was rinsed to position D, waited for 60 seconds 
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(sec) and then the remaining 5 ml ethanol were flushed to syringe D. At position A, a 
new syringe with 10 ml H2Odd was added and flushed to D with a new syringe and 
back to syringe A. This was repeated at least three times. 
The matrix of the cartridge was coated with fibronectin (2.5 #g/ cm2). The syringe 
with fibronectin solution was put on position A and a new, empty syringe was 
attached on D. Then the side port slide clamps C was opened, so that the “off” was 
facing to the cartridge. The stopcock on position D was turned to the “off “ position 
facing to the cartridge. Fibronectin was flushed from A to syringe C through the fiber 
and flushed back to syringe A. The side port slide clamp on position C was closed 
and the D stopcock was opened facing away the cartridge. The fibronectin was then 
rinsed from syringe A to D. The side port slide clamp B was opened and stopcock on 
position A was closed to “off”, facing away from cartridge. Fibronectin was then 
flushed from syringe D to B and back to syringe D. Side port slide clamp B was 
reclosed. The half fibronectin was rinsed from D to A and coating was performed for 
1h at 37°C, 5% CO2. All side port slide clamps were closed and the stopcocks were 
facing towards the cartridge. 
A sterile flask (125 ml) was filled with Endothelial cell medium (PromoCell) with a 
sterile flask cap and cartridges were connected to the flask via plastic hoses for 
medium flow. The fiber matrix was filled with medium by flushing it from syringe A to 
D. All ports were closed with sterile luer caps. Medium was pumped to the system 
until the cartridge was completely filled, preculture was done with pump on low stroke 
1 over night (oN). 
The next day, the cartridge was put back to the laminar flow hood and the medium in 
the flasks was changed to serum free endothelial cell medium-SFM (PAA), and 
pumped manually to the system. 
Cells from a 75 cm2 flask were used for one cell culture cartridge. 10 ml cell 
suspension was filled in a new syringe on position A. New syringes were also 
attached to positions B, C, and D side port slide clamps on B and C were closed and 
stopcocks A and D facing away from cartridge. Cell suspension was gently flushed 
three times between position A and D, so that half of the volume was remaining in 
both syringes A and D. Stopcock on position A was closed, facing “off” towards the 
cartridge and slide clamp B was opened. Cells were rinsed from syringe D to syringe 
B. Side port slide clamp B was closed and slide clamp C was opened instead. Cells 
were flushed from syringe D to syringe C. Followed by closing position D and 
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opening of position A. Cell suspension was flushed from syringe A to syringe C. All 
ports were closed with sterile luer caps. Cell cartridges were incubated at 37°C in the 
incubator, and each 30 min the cartridge was turned 90 ° for cell attachment all over 
the fiber matrix. 
The endothelial cartridge was connected to the perfusion equipment with a 50 ml 
perfusion syringe filled with SMF medium. The perfusion-syringe is attached via port 
A to the cell cartridge, with stopcock “off” in direction towards the tapered plastic 
hose. The perfusion velocity was 10 ml per hour (h). 
The outflow plastic hose was connected to a small T25 flask for collection of 
perfusionsolution, to determine the amount of cells, which could not attach to the 
fiber matrix. All ports were closed with sterile luer caps. Endothelial cartridge was 
connected to the pump and low stroke 1 was simulated oN. Another cell cartridge 
was connected to pump and high stroke was simulated oN. HCAEC were subjected 
to high stroke-HSS (25 dyne/cm2) and low stroke-LSS (2.5dyne/cm2). After 24h the 
medium was changed. Chronic sheer stress was simulated for 9 days and then cells 
were harvested by trypsin/EDTA solution.  
First, cells in cartridge were washed with PBS from port A to port C. Trypsin /EDTA 
solution in syringe on port A was flushed in cartridge and incubated for 4 min, then 
flushed between A and C for 1 min.  The cells were collected in syringe C. Cell 
suspension was centrifuged at 2 x g, 5 min at room temperature (RT). Cell pellet was 
stored at -20°C. 
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2.3 Molecular Biological Methods: RNA/DNA 
 
2.3.1 Isolation of total RNA with TRI Reagent  
 
HCAEC cells were directly lysed in 1ml TRI Reagent (Sigma) per 3.5 cm diameter 
dish, by passing it several times through a pipette. Tissue samples were 
homogenized in 1 ml TRI Reagent per 50-100 mg of tissue with a polytron. 
The samples were incubated for 5 min at RT for dissociation of nucleoprotein 
complexes. After incubation, per 1 ml of TRI Reagent, 0.2 ml of chloroform were 
added and mixed vigorously before an incunation at RT for 3 min. The samples were 
centrifuged at 12,000 x g for 15 min at 4°C. The aqueous phase was transferred to a 
fresh tube and mixed with 0.5 ml isopropyl alcohol per 1 ml TRI Reagent. Samples 
were incubated 10 min at RT and centrifuged at 12,000 x g for 10 min. The RNA 
precipitate was washed with 75% ethanol followed by centrifugation at 7,500 x g for 5 
min at 4°C. The RNA pellet was air-dried and resuspended in ultra pure water (H2O 
up). Finally, RNA was incubated at 55°C for 10 min and stored at -70 °C. RNA 
concentration was measured in ng/#l with Nanodrop 2000 based on the absorbance 
at 260 nm.  
 
 
2.3.2  cDNA Synthesis  
 
Synthesis of cDNA was performed by using the SUPERScript™ RNase H- Reverse 
Transcriptase from Invitrogen. Total RNA (1-5 #g) was used for reverse transcription 
and diluted to a total volume of 10 #l. Following components were added and mixed 
in a sterile eppendorf tube.  
 
1-5 #g  total RNA 
1 #l  oligo (dT) primer (500 #g/ml) 
1 #l  dNTPs (10nM) 
x #l  H2Oultra pure (up) to a final volume of 10 #l 
 
The mixture was heated to 65°C for 5 min and then chilled on ice for some sec.  
   34 
The following components were added and gently mixed: 
 
4 #l  5x First Strand Buffer 
2 #l DTT (0.1 M) 
 
The content was incubated at 42°C for 2 min, and 1 #l of SUPERScript ™ II RT 
(reverse transcriptase (200 U/#l) was added and cDNA synthesis was performed at 
42°C for 50 min. The reaction was stopped by heating to 70°C for 15 min. 
 
 
2.3.3 Polymerase Chain Reaction (PCR) 
 
A reaction volume of 50 #l was used for PCR.  The following components were 
pipetted on ice in a sterile PCR-tube: 
 
39 #l  H20up  
5 #l  10 x High Fidelity PCR Buffer containing 15mM MgCl2 
2.5 µl  DMSO  
1 #l   dNTP mix (10 mM) 
1 #l   forward primer (20pM) 
1 #l   reverse primer (20pM) 
1 #l  cDNA template  
0.5 µl  Expand High Fidelity enzyme mix (5U/#l) 
  
The PCR reaction was performed in T3000 thermocycler (Biometra) and different 
PCR conditions were used, depending on the primer set. A touch-down 
thermocycling program was performed for optimization of PCR conditions. PCR 
products were separated by agarose gel electrophoresis. 
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Denaturation 94°C 30 sec 
Annealing 65°C 30 sec 
Extension 72°C 30 sec 
Final extension 72°C 10 min 
Pause 4°C $ 
Table 2.3 PCR conditions (40 cycles) 
Lid temperature 94°C $ 
Denaturation 94°C 1 min 
Annealing 65°C 1 min 
Extension 72°C 30 sec 
Denaturation 94°C 1 min 
Annealing 59°C 1 min 
Extension 72°C 30 sec 
Final extension 72°C 6 min 
Pause 4°C $ 
Table 2.4 Touchdown PCR conditions (40 cycles) 
 
 
2.3.4 DNA Gel-Electrophoresis 
 
Separation of DNA was obtained by agarose gel electrophoresis on a 1% agarose 
gel. DNA samples were mixed with 5x DNA loading buffer and for size determination 
a 1kB Plus DNA ladder (Invitrogen) was used. Gel electrophoresis was performed at 
100 Volt (V) for 20 min. For visualization of DNA products under ultraviolet light (366 
nm), the agarose gel contained the intercalating dye ethidium bromide (10 mg/ml). 
 
50 x TAE, pH 8.0   5x DNA loading buffer (xylencyanol) 
2 M Tris-HCl    50% glycerol 
1 M acetic acid   0.1M EDTA 
0.1 M EDTA    bromphenol blue 
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2.3.5 DNA Gel Extraction  
  
The Xact DNA Gel Extraction Kit (Genexpress) was used for the elution of DNA 
fragments from agarose gel. 
DNA bands were excised from the gel with a sterile scalpel and transferred into an 
eppendorf tube. The gel fragment was dissolved in 400 µl binding buffer II provided 
by the gel extraction kit and incubated at 55°C until the gel was dissolved.  
The solution was transferred to a Xact column and incubated for 2 min and 
afterwards centrifuged at 10,000 rpm (table-top centrifuge-eppendorf) for 2 min. The 
flow through was discarded. The samples were washed with 300 µl wash buffer and 
centrifuged at 10,000 rpm for 2 min, another washing step with 200 µl was done and 
another centrifugation step for 2 min, 10,000 rpm was performed to remove all wash 
buffer.  
The Xact column was transferred to a new eppendorf tube and 40 µl of elution buffer 
was pipetted on the center of the column and incubated for 2 min at RT. To elute the 
DNA, centrifugation at 10,000 rpm for 2 min was performed. The purified DNA was 
stored at -20°C. 
 
 
2.3.6 Real Time PCR 
 
Real time quantitative PCR (qPCR) was performed with LightCycler® 480 system 
(Roche Applied Science) in LightCycler® 480 Multi-well plates 96.  
A 1:10 serial dilution was prepared with PCR gel elution of a housekeeping gene.  
 
Primers were used in a concentration of 20 pmol.The template was not diluted and 
1.5 #l were pipetted per well. 
 
Mastermix components: 
4.5 #l   H2Oup 
0.75 #l  forward primer 
0.75 #l reverse primer 
7.5 #l  SYBR LC FAST (Peqlab) 
13.5 #l per well 
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After an initial step of denaturation at 95°C for 10 s, an annealing temperature (65-
66°C) depending on primer pairs, was used for 15 sec, followed by extension at 74°C 
for 15 sec and at least a single elongation step at 79°C for 1 sec was performed. 
Fluorescence was measured and signals were quantified within the linear range of 
the standard curve with LightCycler® 480 Software. 
 
 
2.4 Molecular Biological Methods: Proteins 
 
2.4.1 Preparation of lipoproteins 
 
Native LDL was isolated from human plasma by sequential density gradient 
ultracentrifugation with potassium bromide (density 1.019- 1.063).  
Blood plasma (density=1.006) was adjusted to VLDL density of 1.019 with potassium 
bromide (KBr) using the formula and KBr/EDTA solution. 
 
Formula:   g (KBr)   =   Vol (plasma) x (D2-D1) / 1 – (0.321 x D2) 
 
Vol = volume in ml  D = density  
 
Plasma with density 1.019 was transferred to centrifugal tubes (Beckman 2 mm x 89 
mm) with flow through a syringe needle (18 gg). The tubes were heat sealed and 
centrifuged for 20h at 55 K at 14°C with 50,2 Ti rotor in an ultracentrifuge (Beckman). 
The top VLDL fraction was removed and bottom LDL and HDL section was adjusted 
to a density of 1.063 with potassium bromide and KBr/EDTA solution. After 
ultracentrifugation at 55 K for 24h the top LDL fraction was removed and desalted 
using a PD-10 desalting column (GE healthcare) to manufacturer’s recommendation. 
The equilibration of the column was done with LDL buffer (density 1.006). The HDL 
fraction was obtained from the bottom by adjusting the density to 1.21 with potassium 
bromide and KBr/EDTA solution and ultracentrifugation at 55 K for 36h [Goldstein et 
al, 1998]. 
 
 
 
   38 
LDL buffer (1x) pH 7.4 
150 mM NaCl 
0.24 mM EDTA 
 
2.4.2 Modification of lipoproteins 
 
Modification of lipoproteins was done in collaboration with the department of medical 
chemistry Vienna. 
LDL (200 to 500 #g/ml) was oxidized by incubation with copper ions (60 #M/mg 
protein) at 37°C in PBS pH 7.4 for 4h and 24h. The oxidation reaction was stopped 
by addition of EDTA (120 #M/mg protein) and the preparation was subjected to gel 
chromatography to eliminate copper ions. 
 
Carbamylated LDL (up to 5mg/ml) was prepared using potassium cyanate (20 mg/mg 
protein) in PBS pH 7.4 containing 100 #M EDTA at 37°C. Subsequently, the 
preparation was subjected to gel chromatography to eliminate unreacted cyanate.  
 
Glycation of LDL (up to 5mg/ml) was performed with 100 mM glycolaldehyde in PBS 
pH 7.4 containing 100 #M ETDA for 24 h at 37°C. At the end of incubation, the 
preparation was subjected to gel chromatography to eliminate free aldehyde.  
The final modification preparations were stored at 4°C in presence of 50 #M EDTA. 
The modification process of LDL was estimated by relative electrophoretic mobility 
(REM) on a 1.2% agarose gel. 
The extent of LDL oxidation was determined by quantification of thiobarbituric acid-
reactive substances (TBARS). Malondialdehyde (E. Merck, Darmstadt, FRG) was 
used as a standard. 
Electrophoresis was run at 90V for 60 min. The gel was fixed in ethanol-acetic acid 
for 10 min and afterwards shortly rinsed in destaining solution, and stained in fixing 
solution with 0.1% coomassie for 2h. Then the gel was destained with destaining 
solution. 
 
Fixing solution 
ethanol-acetic acid (50%:10%; v:v) 
 
   39 
Destaining solution 
ethanol-acetic acid (5%:7%; v:v) 
 
2.4.3 Cytotoxicity assay 
 
Human coronary artery endothelial cells (HCAEC) were cultured in 96 well plates 
with a density of 2,000-5,000 cells per well. Cells were treated with different modified 
LDL (25 #g or 100 #g) or with native LDL (25 #g or 100 #g) for 19h in serumfree 
endothelial cell medium (SFM), containing 2mM glutamine, 100 U/ml penicillin, and 
100 #g/ml streptomycin. Another set of cells was incubated with 17-beta estradiol (50 
nM) to estimate the vasoprotective effect and treated with different modified LDL (100 
#g) for 19h in SFM. To verify protective effect of HDL, another set of cells were 
pretreated with both HDL (30 #g or 100 #g) and different modified LDL (100 #g) for 
19h in SFM.  
After incubation, cell cytotoxicity was estimated by measuring lactat dehydrogenase 
(LDH) release in medium and total lysed cells using the CytoTox 96 Non- 
Radioactive Cytotoxicity Assay kit purchased from Promega, according to the 
manufacturer`s protocol. 2 #l of LDH positive control, delivered with the kit, was 
diluted in 10 ml PBS with 1% BSA (1:50 000 dilution). Substrate mix was 
reconstituted, by mixing 12 ml of assay buffer with a bottle of substrate mix.  
After incubation time, 50 #l of medium were transferred to an enzymatic assay plate 
(Greiner) and 50 #l of reconstituted substrate mix were added per well and incubated 
for 30 min at RT, protected from light. The reaction was stopped by addition of 50 #l 
stop solution to each well.  Meanwhile, total LDH release was measured by total lysis 
of cells with 10 #l of lysis solution per 100 #l remaining medium for 45 min at 37°C.  
The total LDH release was measured by the same procedure as the spontanous LDH 
release. The absorbance of the LDH mediated conversion was measured at 490nm 
using the Viktor3 V microplate reader (Perkin Elmer). 
Percent cytotoxicity was calculated as ratio of experimental LDH release in medium 
to the total LDH release of lysed cells. 
All experiments were performed in triplicates (n=3). 
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2.4.4 Protein measurement 
 
Protein was measured with Quick Start Bradford 1x Dye Reagent (BIORAD) and 
bovine serum albumin (BSA, 2 mg/ml) as standard as followed with the Bradford 
method. 10 mg of BSA were used as standard in 1 ml of Bradford reagent. 1 #l of 
protein-extract was diluted in 1 ml of Bradford reagent and then analysed with UV 
spectrometer at 595 nm. Protein concentration was calculated as followed: 
 
#g standard                   OD sample       
OD standard                      #g sample 
 
 
LDL concentration was measured by Modified Lowry Protein Assay Kit (Thermo 
scientific, Pierce Protein Research Products). 
Protein concentration of native LDL was determined by using a Modified Lowry 
Protein Assay Kit (Pierce), performed as manufacturer’s recommendations. 
A set of protein standard with concentrations of 10, 20, 40, 80 mg/ml were prepared 
with BSA (1 mg/ml). Lipoprotein-sample was prediluted 1:10 in H2Odd, and 20 #l and 
40 #l of LDL dilutions were used for measurement. 
To total volume of 200 #l, 1 ml of Modified Lowry Reagent was added, mixed and 
incubated at RT for 10 min. At the end of incubation, 100 #l of prepared 1X Folin- 
Ciocalteu Reagent were added, mixed and incubated for 30 min at RT. Absorbance 
was measured with spectrophotometer at 750 nm, after blank correction. For protein 
determination blank corrected value of lipoprotein sample was plotted against BSA 
standard curve. 
 
 
2.4.5 SDS- Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
Cell extracts were separated by SDS-PAGE with a thickness of 1 mm using the 
BIORAD system. The components of the separating gel were mixed and poured into 
a cleaned gel unit and overlaid with isopropanol. Stacking gel was poured onto 
polymerized separating gel after removement of isopropanol. 
    =     #g/#l protein  
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The combs were inserted and the stacking gel was allowed to polymerize. After 
removal of the comb, the gel was put into the buffer chamber and filled with 
electrophoresis buffer.  
  
 
Components for 2 gels Separation gel 6% Stacking gel 4% 
H2O dd in ml 5.35 3.05 
0.5 M Tris (pH 6.8) in ml - 1.25 
1.5 M Tris (pH 8.8) in ml 2.50 - 
Polyacrylamide (30% 
PAA) in ml 
2 0.65 
SDS (10%) in #l 100 50 
APS (10%) in #l 50 25 
TEMED in #l 10 10 
Table 2.5 Composition of gels used for SDS-PAGE 
 
0.5 M Tris-HCl Buffer     1.5 M Tris-HCl Buffer 
0.5 M Tris-HCl pH 6.8                                        1.5 M Tris-HCl pH 8.8 
 
30% Polyacrylamide    1x Electrophoresis Buffer 
29.2% Acrylamide     250 mM Tris-HCl 
0.8% N,N`-Methylenbisacrylamide  192 mM Glycine 
       0.1% Glycine 
 
 
2.4.6 Westernblotting 
 
Cell lysates were loaded on the SDS-gel under reducing ("-mercaptoethanol) or non-
reducing conditions with 4x Laemmeli loading buffer. In the case of reducing 
conditions, the samples were heated to 95°C for 5 min before loading. One slot was 
loaded with 10 #l of Precision Plus Protein™ Unstained Standard (BIORAD), which 
served as size marker.  
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The gel was run at 180V for ~1h, until the bromphenolblue front reached the bottom 
of the gel. The gels were used for western blotting or direct staining with Coomassie 
blue or Silver Stain. 
Proteins were transferred to nitrocellulose membrane (Hybond™-C Extra, Amersham 
Bioscience). The blot was prepared as followed: 1 fibre pad was applied to the 
blotting unit with 3 Whatman papers soaked with transfer buffer and followed by 
nitrocellulose membrane and the gel. Finally three whatman paper and 1 fibre pad 
were added on the other side of the blotting unit. Air bubbles were removed by rolling 
a tube over the blot. The blotting unit was put into the blotting chamber filled with 
transfer buffer in an ice box. Wet tank blotting was done at 200 mA per gel for 1-1.30 
min. 
Transfer efficiency was checked by Ponceau S staining of the membrane, blotted 
proteins and the standard were visualized by destaining with H2Odd.  The protein 
standard and the lanes were marked with a membrane pencil and excess parts of the 
membrane were cut off. 
The membrane was blocked in blocking solution for 1h at RT. After blocking, 
incubation with primary antibody was done oN at 4°C on a shaker. Dilutions of the 
primary antibody were dependent on the primary antibody affinity. The membrane 
was washed three times with TBS-T each 10 min, followed by incubation with the 
secondary antibody-HRP conjungated for 1h at RT by gentle agitation. The 
membrane was washed three times with TBS-T, each 10 min. Finally, the 
immunoblot was incubated with ECL solution I and II (mixture 1:1) for 5 min at RT 
and put into the exposure cassette. Films were exposed in dark room for a few 
seconds up to 30 minutes, developed by AGFA developing maschine. 
 
 
4x Laemmli buffer (reducing)    4x Laemmli buffer (non reducing) 
31.2 % Glycerine     31.2% Glycerine 
6 % SDS       6% SDS 
20 mM Tris-HCl, pH 7.4    20 mM Tris-HCl, pH 7.5 
Bromophenol-blue     Bromophenol-blue 
25 mM Dithiothreitol (DTT)   Add H2Odd to 20 ml 
Add H2Odd to 20 ml 
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1x Electorphoresis buffer    1x Transfer buffer 
25 mM Tris-HCl     25 mM Tris-HCl 
192 mM Glycine     192 mM Glycine 
1% SDS 
 
Ponceau S      Bloking solution    
0.2 % Ponceau S     5% non fat dry milk  
3% trichloracetic acid    1x TBS-T     
Dilute with 1x TBS 
 
TBS-T      10x TBS 
1x TBS      1.37 M NaCl 
0.1% Tween 100     0.027 KCl 
       0.25 M Tris-HCl 
       With HCl to pH 7.4 
 
 
2.4.7 Co-Immunoprecipitation 
 
Co-Immunoprecipitaion is based on the principle of the interaction of proteins. 
Ni-NTA agarose (QIAGEN) with a binding capacity of 50 mg His-tagged protein/#l 
bead suspension was used for binding of recombinant His-tagged RAP protein. 500 
#l of RAP protein were added to 100 #l of Ni-NTA beads in TBS-T with 2 mM CaCl2 
and protease inhibitor and incubated oN at 4°C on a rotator. The next day, the 
samples were centrifuged at 3,500 rpm (table-top centrifuge-eppendorf) for 5 min at 
4°C and the supernatant was discarded. The beads were washed three times with 
TBS-T with 2 mM CaCl2. Then appropriate amount of cell lysate was added to the 
RAP-linked Ni-NTA beads in TBS-T with 2 mM CaCl2 and incubated oN at 4°C on a 
rotator. The next day, the samples were centrifuged at 3,500 rpm for 5 min at 4°C 
and the supernatant was discarded. The beads were washed three times with TBS-T 
with 2 mM CaCl2. . The beads were mixed with 4x Laemmli buffer (reducing) and 
heated to 95°C for 5 min to separate the proteins from the beads. Samples were 
applied to SDS-PAGE and analysed by silver staining. 
 
   44 
2.4.8 Coomassie–blue staining 
 
After SDS-PAGE the gel was removed from the glass plates and covered with 
Coomassie staining solution for 1h at RT with gentle agitation. The gel was destained 
with destaining solution with gentle agitation, changing the destaining solution at 
least three times. To preserve the gel, it was dried by vacuum (BioRad) at 60°C for 
1h. 
 
Coomassie Solution     Destaining solution 
10% acetic acid      10% acetic acid (v:v) 
25% isopropanol      30% methanol (v:v) 
0.862 g Coomassie Blue R250 
up to 2L with H2Odd 
 
 
2.4.9 Silver Stain 
Silver stain of proteins after SDS-PAGE was performed by SilverSNAP Stain Kit II 
from Pierce. All steps were performed in a clean plastic tray with gentle agitation.  
After electrophoresis, the gel was washed two times in sterile H2Odd for 5 min. 
Fixation of proteins was done by incubation of the gel in fixing solution two times for 
15 min. Afterwards, the gel was washed with two changes of 10% ethanol and two 
changes of sterile H2Odd for 5 min. The gel was incubated in Sensitizer Working 
Solution for 1 min and then washed with two changes of sterile H2Odd for 1 min. The 
Work Stain Solution was added to the gel and incubated for 30 min and subsequently 
washed two times with sterile H2Odd for 20 sec. Developing was performed with 
Developer Working Solution, until protein bands appeared. Stop Solution, 5% acetic 
acid, was added to the gel tray to stop developing reaction. At least the gel was 
incubated in H2Odd for 10 min. For storage, the gel was dried using the vacuum 
dryer at 70°C for 1h. 
 
 
Fixing solution     Sensitizer Working solution  
30% ethanol      50 #l of sensitizer 
10% acetic acid     up to 25 ml H20 steril 
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Work stain solution      Developer Working solution 
0.5 ml Enhancer     0.5 ml Enhancer 
25 ml Stain      25 ml Developer 
 
2.5 Statistical Analysis 
 
Data are expressed as +/- standard deviation. The Student’s t-test was employed to 
explore whether differences in parameters measured in cytotoxicity assays were 
statistically significant. The significance value was set to p< 0.05 and calculated as 
triplicates n=3. 
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Chapter 3 
 
Results 
 
Endothelial dysfunction is an early marker of atherosclerosis. Several diseases are 
marked by atherosclerotic plaque progression in coronary arteries through modified 
lipoproteins. 
Different modified lipoproteins were already observed as oxidized LDL, glycated LDL 
(diabetes), and carbamylated LDL (kidney disease), depending on disease state. 
Even so, during aging modified LDL exist also in healthy people, but the extent of 
different modified LDL increases with disease mentioned above. 
The focus of this study was to investigate, how human coronary artery endothelial 
cells alter their gene expression after exposure to different modified LDL. Published 
data revealed the increase of inflammatory sensors as I-CAM and E-selectin in first 
atherosclerotic events. In addition, previous studies focused on the upregulation of 
scavenger receptors for clearance of modified LDL.  
In this study the interest was focused on the role of LDL receptor gene family 
members including LDLR, LRP1, and LRP2 in HCAEC and further to investigate the 
effect of E2 and HDL on HCAEC. 
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3.1 Modification of lipoproteins in vitro 
 
For in vitro modification of lipoproteins, native LDL from blood of healthy individuals 
was isolated by sequential gradient ultracentrifugation with potassium bromide. Blood 
was exclusively isolated from men. 
Lipoproteins could be separated into different fractions by their density. After 
ultracentrifugation for 20h with a density of 1.019, the VLDL fraction could be isolated 
at the top of the centrifugal tube (Fig.3.1-A).  
Native LDL was isolated after additional centrifugation for 24h with a density of 1.063 
(Fig.3.1-B). At least HDL was isolated after centrifugation for 36h with  a density of 
1.21, seen as fraction also at the top of the centrifugal tube (Fig.3.1-C). 
 
 
 
 
Fig.3.1 Isolation of lipoproteins from healthy individuals. All lipoproteins including 
VLDL, LDL, and HDL were isolated from the top of the tube after density gradient 
centrifugation. VLDL with density of 1.019 (A), LDL with density 1.063 (B), and at 
least HDL with density of 1.21 (C). 
 
Modifications of lipoproteins were performed in vitro by chemical reactions. Oxidized 
LDL was attained by chemical reaction with copper ions, carbamylated LDL was 
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obtained by incubation with KOCN, and glycated LDL by incubation with 
glycerolaldehyd. 
To estimate the modification processes relative electrophoretic mobility (REM) and 
thiobarbituric acid-reactive substances (TBAR) assay were performed (data not 
shown). REM of lipoproteins was monitored on an agarose gel and subsequently by 
Coomassie staining. Different migration through the gel could be used to estimate 
modification status. 
Native unmodified LDLs (Fig.3.2, lane 1-3) did not migrate as far as modifed LDL 
(Fig.3.2, lane 4-8), because its positive charge on the lipoprotein shell. The 
modification neutralizes modified LDL, therefore it can migrate further on the gel. 
Neutralization of positive charge allows the migration of oxidized, glycated, and 
carbamylated LDL.  
Oxidation of LDL leads to reactive aldehydes via the addition of reactive oxygen to 
unsaturated carbon double bonds of lipids or amino acids and thereby obtaining a 
negative charge [Himmelfarb, 2002]. LDL oxidized for 24 h (Fig.3.2, lane 5) migrates 
further compared to LDL oxidized for 4h (Fig.3.2, lane 4), because of more oxidized 
apoB 100 after 24h. Carbamylation results in neutralization of positive charge of 
modified lysine [Ok, 2005] and glucose modification also neutralizes positive charge 
of lipids and amino acids. 
Each modification experiment has its varitions, because of different blood donors and 
also chemical modifications can fluctuate. Modification reaction such as 
carbamylation and glycation resulted in no change in REM, compared to oxidized 
LDL. 
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Fig.3.2 Analysis of modification processes by REM on an 1.2 % agarose gel with 
subsequent Coomassie staining (0.1%). Lane 1-3 native LDL, lane 4 and 5 oxidized 
LDL (ox LDL 4h and 24h), lane 6 and 7 carbamylated LDL (carb LDL 4h and 24h), 
and lane 8 glycated LDL (gly LDL 24h). 
Further the formation of tiobarbituric acid reactive substances in the case of oxidized 
LDL was measured. Malondialdehyd was used as standard. Through oxidation 
reaction reactive radicals were built. Data of TBAR assay are not shown. 
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3.2 Human coronary artery endothelial cells (HCAEC) 
 
 
Fig.3.3 Morphology of HCAEC incubated with different modified LDL and E2 compared to 
control cells Cell morphology and growth to confluency in HCAEC control in SFM without 
incubation (1), incubated with E2 (2), with ox LDL (3), and with E2 and ox LDL (4) HCAEC 
were cultured in 60 mm dishes. 20 fold magnification. 
 
The interest was, if human coronary endothelial cells (HCAEC) alter their morphology 
after exposure to different modified LDL for 19h. Studies showed the remodelling of 
endothelial cells in contact with modified LDL. Further, if incubation with E2 had a 
positive effect on cell behaviour, when incubated with modified LDL as well. 
Normal untreated cells in SFM (Fig.3.3-1) and also cells with E2 (Fig.3.3-4) seemed 
to proliferate and grow to confluency, but cells incubated with modified LDL (Fig.3.3-
3) seemed to change their cell morphology. As seen in Fig.3.3 (3 and 4) cells formed 
stretches and lost their round shape. Also cells tended to form cell islands. 
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3.3 Determination of cytotoxicity of modified LDL to HCAEC 
 
Based on the change of cell growth behaviour and alteration in morphology after 
treatment with modified LDL, the cytotoxic effect of modified LDL was determined. 
A cytotoxicity assay was performed to measure the release of lactat dehydrogenase 
from cells. Experimental LDH release could directly be associated with cell damage 
and apoptosis. 
For incubation of HCAEC with different modified LDL, concentrations of 25 #g and 
100 #g were used. Further investigation was done, to analyze if E2 and HDL can 
antagonize the cytotoxic effect of modified LDL. 
 
 
 
Fig.3.4 Cytotoxicity of 100 !g compared to 25 !g of modified LDL                                               
HCAEC were incubated with modified LDL (100, 25 #g) in SFM, average experimental LDH 
release in medium of cells was determined. Total LDH release could be measured by lysing 
the cells. Percent cytotoxicity was calculated as ratio of experimental LDH release to total 
LDH release. p values were calculated to native LDL as triplicates n=3. 
An incubation of HCAEC with 25 #g compared to 100 #g was not highly toxic. 
However a baseline apoptosis of cells about ~15%-20% could be estimated (Fig.3.4).  
Copper oxidized (ox LDL 24h), carbamylated (carb LDL 4h), and glycated LDL (gly 
LDL 24h) showed a higher cytotoxic effect with a treatment concentration of 100 #g. 
Strongest cytotoxic effect was detected with 100 #g of oxidized LDL. For the 
following experiments a concentration of 25 #g of modified LDL was used. 
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Fig.3.5 Cytotoxicity of modified LDL and protective effect of HDL Cells were incubated 
with 100 #g of different modified LDL with or without HDL (30 #g). The HDL/LDL 
concentration was used in a ration 1:3, according to human physiology. The incubation of 
HCAEC was done for 19h in SFM and LDH release was measured as described in Fig 3.4. p 
values were calculated to native LDL as triplicates n=3. 
 
HDL was defined as protective molecule that antagonizes the oxidative stress in 
vasculature. Cytotoxic effect was lower after incubation of HCAEC with modified LDL 
(100 #g) in the presence of HDL (30 #g) seen in Fig.3.5. The concentration ratio of 
HDL (30 #g) to LDL (100 #g) reflects human blood circulation. 
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Fig.3.6 Cytotoxicity of modified LDL and protective effect of E2 HCAEC were incubated 
with 100 #g of different modified LDL and also with or without E2 (50 nM) for 19h in SFM. 
The LDH release was measured as described in Fig 3.4. p values were calculated to native 
LDL as triplicates n=3. 
 
Moreover, incubation with E2 showed a potent decrease in cytotoxicity when 
incubated with oxidized and carbamylated LDL. Interestingly, no decrease in 
cytotoxicity could be determined in the case of glycated LDL with E2 (Fig.3.6). The 
explanation could be that diabetes comes along with elevated levels of glycated LDL 
and that the effect of estrogen is abolished in this disease. 
 
Concluding the data, 25 #g of modified LDL showed no detrimental cytotoxic effect to 
HCAEC in cell culture compared to 100 #g modified LDL. A 1.5 to 2 fold increase in 
cytotoxicity could be detected with a concentration of 100 #g of different modified 
LDL. To confirm the positive effect of estrogen and HDL, cytotoxicity decreased after 
incubation with modified LDL (100 #g) seen in Fig.3.5 and Fig 3.6.  
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3.4 Expression analysis of LDL receptor gene family members in 
HCAEC 
 
The aim of this study was to investigate the expression profile of LDL receptor gene 
family members including the LDL receptor, LRP1, and LRP2 in human coronary 
artery endothelial cells. Further, we wanted to estimate possible alteration in gene 
expression after exposure to different modified LDL, as in atheriosclerotic events. 
The question was if these receptors have a specific function in coronary arteries for 
regulation of lipid metabolism in early atherosclerosis. 
First RT-PCR analysis was performed followed by determination of quantitative 
expression level (qPCR) of LDL receptor, LRP1, and LRP2 in HCAEC. The absolute 
quantification was used to compare mRNA expression of different receptors. 
 
 
3.4.1 RT-PCR analysis 
 
PCR analysis showed an overall detetction of LDL receptor, LRP1 and LRP2 DNA 
fragment in human coronary artery endothelial cells. Total RNA was isolated from 
HCAEC after incubation with modified LDL and also after doubletreatment with E2. 
RNA was reverse transcribed into cDNA, which was used as template for RT-PCR 
analysis and qPCR. The data obtained from RT-PCR corresponded only partially with 
the results obtained by quantitative PCR analysis. 
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Fig.3.7 RT-PCR analysis of LDLR fragment in HCAEC using a touchdown PCR 
program. RNA was isolated and reverse transcribed into cDNA, which was used as 
template for RT-PCR. The forward primer LDL_TMD1 and reverse primer LDL_TMD2 
were used. Primers were designed for transmembrane domain of LDLR and 
generated a fragment of 133bp. Lane 1 untreated cells (ctrl), lane 2 HCAEC 
incubated with native LDL (n LDL), lane 3-5 detected PCR products with incubation of 
HCAEC with modified LDL (25 #g) and lane 6-9 detected LDLR fragments in HCAEC 
treated with modified LDL and E2 (50nM).  
 
LDL receptor PCR products could be detected by RT-PCR seen in Fig.3.7, 
also LRP2 could be observed in HCAEC seen in Fig.3.8. PCR production of 
LRP1 (Fig.3.9) was not as strong compared to the two other receptors, only in 
the case of oxidized LDL treated HCAEC Fig.3.9 (lane 3). LRP1 seemed to be 
stronger with E2 as seen in Fig.3.9 (lane 6-11). 
 
   
 
Fig.3.8 RT-PCR analysis of LRP2 fragment in HCAEC using a touchdown PCR 
program. RNA was isolated and reverse transcribed in cDNA used as template for 
RT-PCR. PCR product with fragment size of 237bp was generated with the primer 
hu_LRP2 (12fwd) and hu_LRP2 (13 rev). Lane 1 untreated HCAEC (ctrl), lane 2 
HCAEC incubated with native LDL (n LDL). Lane 3-5 show that LRP2 PCR product in 
HCAEC with modified LDL (25 #g) and lane 6-10 showed LRP2 fragment in HCAEC 
with modified LDL (25#g) and E2 (50nM). Lane 11 untreated cells as control (crtl). 
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Fig.3.9 RT-PCR analysis of LRP1 fragment in HCAEC using a touchdown PCR 
program. RNA was isolated and reverse transcribed in cDNA, which was then used 
as template for RT-PCR. PCR product with fragment size of 234bp was generated 
with the primer hu_LRP1 (11fwd) and hu_LRP1 (12 rev). Lane 1 demonstrated LRP1 
PCR product of untreated cells (crtl) Lane 2-5 showed HCAEC with modified LDL (25 
#g), no band could be detected with glycated LDL lane 5. Lane 7-11 showed LRP1 
PCR fragment of HCAEC with E2 (50nM) and incubation with modified LDL (25#g). 
 
The mRNA expression level of LRP2 should be elucidated under static conditions in 
cell culture and further by using the chronic shear stress module (Fiber Cell™ 
module). HCAEC were grown in this cell cartridge and subjected to LSS and HSS. 
Cells were harvested and RNA was isolated followed by reverse transcription. Two 
conditions were compared as HSS and LSS, also when cells were additional 
incubated with carbamylated LDL. LRP2 is abundantly expressed in human epithelial 
kidney cells (HEK) (Fig.3.10, lane 1), which were used as positive control. 
Transcription  level of LRP2 increased after treatment with E2 (Fig.3.10, lane 2), 
which was discovered in our lab. RT-PCR revealed a low signal of LRP2 under shear 
stress seen in Fig.3.10 in lane 4-7 compared to HEK positive control (Fig.3.10). 
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Fig.3.10 RT-PCR of HCAEC under shear stress RNA was isolated and reverse transcribed 
in cDNA, which was used as template for RT-PCR. PCR product with a fragment size of 
237bp was generated with the primer hu_LRP2 (12fwd) and hu_LRP2 (13 rev). Lane 2 
showed HEK (human epithelial kindey cells), which were used as positive control and in lane 
3 were HEK + (human epithelial kindey cells after E2 treatment for 24h). Crtl (untreated 
HCAEC) could be seen in lane 1, carbamylated LDL under LSS and HSS (cLSS and cHSS) 
and native LDL under HSS and LSS (nLSS, nHSS) 
 
 
3.4.2. Quantitative analysis of mRNA levels under static conditions 
 
Quantitative real time PCR should reveal the differences in the mRNA level of LDL 
receptor family members in normal untreated HCAEC and in HCAEC incubated with 
oxidized, glycated and carbamylated LDL. Further, we wanted to know if the 
genexpression-level changes when cells were doubletreated with E2 and modified 
LDL.  
Real time PCR was performed with LightCycler® 480 and using SYBR Green, 45 
cycles were run. LightCycler® 480 software (version 1.2) was used for quantification. 
The absolute quantification was used to compare mRNA levels under various 
conditions. 
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Fig.3.11 Quantitative PCR analysis of LDLR mRNA in HCAEC incubated with modified 
LDL Undiluted cDNA was used as template for qPCR with the forward primer LDL_TMD1 
and the reverse primer LDL_TMD2. Gene expression was normalized to human-beta actin 
housekeeping gene. 
 
As seen in Fig.3.11, the LDLR mRNA level increased after treatment with ox LDL, an 
approximately 9.3 fold increase compared to control was detectable. Transcription of 
LDLR in samples treated with carbamylated and glycated LDL was slightly higher 
compared to control cells.  
Interestingly, after administration of E2, a significant increase of LDLR transcript in 
control group (Fig.3.12, left panel) was detected. Smith et al, 2004 published that the 
LDLR mRNA level is responding to estrogen treatment in HepG2 cells. Also HCAEC 
showed an effect after E2 treatment. LDLR transcription was arbitrarily set to 100%, 
the LDLR transcription in HCAEC incubated with native LDL decreased to 0.02%. 
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Fig.3.12 Quantitative PCR analysis of LDLR mRNA in HCAEC incubated with modified 
LDL and E2 Undiluted cDNA was used as template for qPCR with the forward primer 
LDL_TMD1 and the reverse primer LDL_TMD2. Gene expression was normalized to human- 
beta actin housekeeping gene. Percentage of gene expression was calculated in comparison 
to the control (ctrl + E2). 
 
 
 
Fig.3.13 Quantitative PCR analysis of LRP1 mRNA in HCAEC incubated with modified 
LDL and E2 Undiluted cDNA was used as template for qPCR with the primers hu_LRP1 
(11fwd) and hu_LRP1 (12rev). Gene expression was normalized to human-beta actin 
housekeeping gene. 
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LRP1 mRNA could not be detected with real time PCR in HCAEC incubated with 
modified LDL without E2 (data not shown). After E2 treatment and incubation with 
modified LDL, LRP1 mRNA level was slightly upregulated (Fig.3.13). 
LRP1 was also detected with RT-PCR at low-level (Fig.3.10), which correlated with 
quantitative mRNA levels of LRP1. LRP1 transcription was higher in control cells 
treated with E2 compared to cells after exposure with ox LDL, carbamylated LDL, 
and glycated LDL also after E2 treatment. A stronger downregulation could be seen 
in samples with carbamylated LDL and E2. 
 
 
 
Fig.3.14 Quantitative PCR analysis of LRP2 mRNA in HCAEC incubated with modified 
LDL Undiluted cDNA was used as template for qPCR with the primers hu_LRP2 (12fwd) and  
hu_LRP2 (13rev) Gene expression was normalized to human-beta actin housekeeping gene. 
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Fig.3.15 Quantitative PCR analysis of LRP2 mRNA in HCAEC incubated with modified 
LDL + E2 Undiluted cDNA was used as template for qPCR with the primers hu_LRP2 
(12fwd) and hu_LRP2 (13rev) Gene expression was normalized to human-beta actin 
housekeeping gene. 
 
LRP2 transcription in HCAEC was similarly correlating to the mRNA level of LRP1 in 
HCAEC after E2 treatement. In contrast, LRP2 transcription level was upregulated by 
glycated LDL. No response of LRP2 in HCAEC control cells treated with E2 could be 
detected. Estradiol seemed to upregulate LRP2 (5 to 10 fold increase) when cells 
were incubated with modified LDL (Fig.3.15) 
 
In HCAEC a very low-level of mRNA expression of LRP1 and LRP2 could be 
detected. Hence, a change in the transcriptional level could be seen after 
doubletreatment with different modified LDL and E2. In the case of treatment with 
glycated LDL, an increase could be detected in both receptors, LRP1 and LRP2. 
LDL receptor is normally expressed in HCEAC, but downregulated in cells treated 
with modified LDL. An abundant upregulation of LDL receptor transcription in HCAEC 
control could be observed when incubated with E2.  
Consequently, modified lipoproteins could not be recognized by LDL receptors 
anymore. The uptake of chemically modified LDL is restricted to scavenger receptors 
on endothelial cells, macrophages and, smooth muscle cells. 
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3.4.2. Quantitative analysis of mRNA levels under shear stress 
 
As mentioned before, mRNA levels of LDLR, LRP1, and LRP2 should be studied 
under static conditions in cell culture experiments. Secondarily, these receptors 
should be detected with cell culture cartridges, where cells can be subjected to shear 
stress. This method could simulate the in vivo situation of human physiology even 
better. 
 
 
Fig.3.16 Fiber Cell™ cartridge [10] 
 
 
Before use, the fibers of the cell cartridge had to be coated with extracellular matrix 
protein fibronectin, to permit the attachment of endothelial cells to the interior wall of 
the fibre. A special microprocessor controlled Fiber Cell™pump produced consistent 
shear stress by regulating the flow of SF-medium through the cartridges. The pump 
generated shear stress of 2.5 dyne/cm2 (LSS) and 25 dyne/cm2 (HSS). Chronic 
shear stress was simulated for 9 days; on day 8 the modified LDL were added to the 
fibre for 19h. HCAEC were harvested and RNA was used for reverse transcription to 
cDNA. 
Real time PCR was performed with Applied Biosystem by using fluorescent primers 
designed and purchased from Applied Biosystem. Results were obtained by 
cooperation with Vienna General Hospital. 
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Fig.3.17 Quantitative PCR analysis of LDLR mRNA in HCAEC incubated with native 
and carbamylated LDL under shear stress Relative gene expression was normalized to 
control of human beta actin, native LDL under high shear stress (nHSS), native LDL under 
low shear stress (nLSS), carbamylatd LDL under high and low shear stress (cHSS and 
cLSS). P values were calculated as triplicates n=3; p>0.05 and p<0.01 
Shear stress differentiated coronary artery cells seemed to downregulate the LDLR 
relative gene expression under LSS. Sites of LSS in cardiovascular regions of the 
heart are more susceptible to atherosclerotic plaque progression. HSS was 
protective and no change in LDLR mRNA with incubation of native or carbamylated 
LDL was seen (Fig.3.17, left panel). Chronic high shear stress could modulate the 
negative effect of modified LDL. Comparison of LSS either with native or 
carbamylated LDL elucidated, that LSS downregulted the LDLR transcription. 
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Fig.3.18 Quantitative PCR analysis of LRP1 mRNA in HCAEC incubated with different 
modified LDL under HSS and LSS Relative gene expression was normalized to control of 
human beta actin, native LDL high shear stress (nHSS), native LDL low shear stress (nLSS), 
carbamylatd LDL high and low shear stress (cHSS and cLSS), glycated LDL high and low 
shear stress (gHSS and gLSS), oxidized LDL high and low shear stress (oxHSS and oxLSS)  
 
 
Quantification of relative LRP1 mRNA expression revealed a downregulation under 
low shear stress, as seen in LDLR gene expression (Fig.3.17). Interestingly, mRNA 
level of LRP1 seemed to be upregulated in cells under LSS treated with glycated 
LDL, also seen under static conditions. The relative LRP1 expression is higher in 
native compared to different modified LDL under HSS. LRP1 could not be detected 
under static condition in cell culture experiments, but after subjection to shear stress. 
This means that shear stress alters transcription and has a fundamental influence on 
mRNA pattern. 
As shown in Fig.3.18, LRP2 mRNA expression did not change under static conditions 
and also a low-level expression could be estimated under LSS and HSS. No 
significant alteration of LRP2 expression could be detected under different 
conditions. 
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Fig.3.19 Quantitative PCR analysis of LRP2 mRNA in HCAEC under HSS and 
LSS HCAEC subjected to low shear stress (LSS) or high shear stress (HSS), 
compared to HCAEC under static (static) in vitro cell culture conditions. Gene 
expression was definded as arbitrary units (AU). 
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3.5 Determination of protein expression in HCAEC in response to 
modified LDL 
 
After detection at the mRNA level, the protein level remained to be elucidated.  
HCAEC cell lysates were prepared under the same conditions and western blotting 
was performed by transfer of the proteins to a nitrocellulose membrane. 
 
 
Fig.3.20 Western blot analysis of LDLR expression in HCAEC treated with different 
modified LDL HCAEC cell lysates (70#g) were subjected to a 8% SDS PAGE under non-
reducing conditions and blotted to a nitrocellulose membrane. For detection, an !-LDLR 
antibody produced by our lab was used with a dilution of 1:700. HRP-conjugated goat !-
rabbit antibody (1:50000) was used as secondary antibody and visualization was performed 
using ECL detection.  
 
LDLR protein expression could be detected in control as well as after treatment with 
different modified LDL. A stronger signal could be detected with oxidized LDL, which 
correlates with results from quantitative PCR (Fig.3.11). Carbamylated LDL resulted 
in a fainter band of LDLR. 
Unfortunetly, these antibodies had a massive background signal. Different LDLR 
antibodies were used as the polyclonal !-rabbit-LDLR produced by our lab and the 
monoclonal !-mouse-LDLR (Calbiochem). LDLR expression could not be detected in 
HCAEC with E2 treatment (data not shown), correlating with the results of 
downregulation of LDLR mRNA by qPCR. 
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Another possible explanation for the impossibility to detect the protein expression of 
LRP1 and LRP2 might be the low detection of these receptors on mRNA level. LRP1 
only could be detected in positive control of mouse liver extract (data not shown). 
To by-pass the problems with the detection of LRP1 and LRP2 westernblotting, LDL 
receptor gene family members were pooled by Co-Immunoprecipitation with RAP. 
With this method LRP1 and LRP2 could not be detected by western blotting after Co-
Immunoprecipitation as well. A silver stain was performed, which is a sensitive 
method for showing proteins, to visualize LRP1 and LRP2 after Co-
Immunoprecipitation with RAP (Fig.3.22). 
 
 
 
Fig.3.21 Co-Immunoprecipitation of LDL receptor family members using cell lysates 
and RAP chaperon After Co-Immunoprecipitation with RAP-His tag to agarose beads oN, 
cell lysates of HCAEC treated with modified LDL or with E2 were added to the beads to 
accumulate LDL receptor family members as LRP2, LRP1. After SDS-PAGE under non 
reduced conditions on a 8% SDS-gel, a silver stain was performed. Lane 1-4 show HCAEC 
treated with native and different modified LDL with E2, lane 5-8 show HCAEC tretaed with 
modified LDL and native LDL, lane 9 untreated cells (control). 
 
The advantage of silver stain is that it detects small amounts of protein. Because of 
the relatively similar size of LRP1 (515 kDa) and LRP2 (600 kDa) in glycosylated 
status, it was difficult to distinguish these two receptors. Detection of LDLR and LRP2 
in HCAEC remains to be elucidated because of the problems with antibodies. Our lab 
is now working to produce a human LRP2 antibody. 
1         2       3       4      5       6      7        8       9 
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Chapter 4 
Discussion 
Atherosclerosis and early markers like endothelial dysfunction can be associated with 
several pathological conditions. The traditional cardiovascular risk factors are high 
blood pressure, dyslipidemia, smoking and, obesity. Patients suffering from diabetes 
mellitus or kidney disease come along with a higher risk of progression of 
atherosclerosis. 
Disease patients have elevated cholesterol levels in their blood circulation. The 
accumulation and subendothelial retention of LDL particles in vasculature contribute 
to modification processes. Depending on the disease, different modified lipoproteins 
were already observed as lipid oxidized LDL, hypochlorite modified LDL, glycated 
LDL, or carbamylated LDL. Besides, modification processes take place during aging. 
General populations have oxidized LDL, normally through oxidants in blood 
circulation. Smoking increases the risk of oxidation of lipoproteins. Hypochlorite 
modified LDL is formed by the myeloperoxidase H2O2-halide system in oxidative 
stress situations. Glycation of LDL increases in patients with diabetes and 
carbamylated LDL devates in patients with chronic renal insufficiency. Modified 
lipoproteins are thought to be even more proatherogenic. Modification of lipoproteins, 
especially LDL, is a key event in atherosclerosis leading to endothelial dysfunction.  
Vascular intima, a monolayer of endothelial cells in coronary arteries, regulates the 
tonus, coagulation, and the proliferation of smooth muscle cells. Endothelial 
imbalance contributes to oxidative stress and upregulation of vasoconstriction 
towards overgrowth of smooth muscle cells. Imbalance of endothelium is associated 
with endothelial dysfunction described as injury of endothelial cells. During this step, 
a change in gene regulation is triggered and remodelling processes get activated. 
 
The aim of this project was to get some insights in lipotoxicity of different modified 
LDL on human coronary artery endothelial cells. To understand the situation of 
endothelial dysfunction and the influence of oxidized, glycated, and carbamylated 
LDL even better.  
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Further interest was to investigate possible changes in gene expression associated 
with the exposure of HCAEC to different modified LDL under static conditions and 
under shear stress. 
 
Much data is known about the cytotoxic effect of modified lipoproteins in different 
concentrations on endothelial cells. Previous studies focused on inflammatory 
sensors such as ICAM-, monocyte chemotactic protein (MCP-1), NF%B and the 
upregulation of specific scavenger receptors such as LOX-1 and CD36 [Moore,2006; 
Zahler, 2000; Zu, 2010]. Scavenger receptors regulate the uptake of modified 
aggregated LDL and clear them from circulation. Such scavenger receptors are 
mainly expressed on macrophages and SMC in advanced atherosclerotic 
progression.  
 
In this study, the question was addressed about early steps of endothelial cell 
damage. Few is known about the regulation and role of LDL receptor family members 
in endothelial dysfunction. The interest was, how endothelial cells alter their gene 
expression pattern in concern to the focus on LDL receptor family members such as 
LDLR, LRP1, and LRP2 after exposure to different modified LDL.  
First, I wanted to determine the cytotoxic effect of different modified LDL as oxidized, 
glycated and carbamylated LDL on HCAEC, to define a non-toxic concentration for 
further experiments. We wanted to study the influence of vasoprotective molecules 
as HDL and estrogen. Many studies revealed the positive effect of estrogen in 
vasculature and the later incidence of CVD in women. Estrogen has multiple vascular 
effects including the alteration in lipid serum levels, fibrinolysis, and antioxidant 
properties [Kublickiene, 2008]. HDL particle and components were characterized to 
have antioxidant properties and counteract processes of modified LDL. 
Incubation of HCAEC with 100 #g of different modified LDL resulted in a higher 
cytotoxic effect than with 25 #g of modified LDL. Oxidized LDL seemed to be the 
most cytotoxic agent to damage endothelial cells. For further experiments, a 
concentration of 25 #g was used, because of no detrimental cytotoxicity of modified 
LDL after incubation of HCAEC.  
The evidence could be enforced that estrogen protects endothelial cells from stress, 
because the cytotoxicity decreased dramatically after incubation of HCAEC with 100 
#g of modified LDL and E2. Additionally, HDL had a potent impact to lower cytotoxic 
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effects of modified LDL on HCAEC. Concluding, that incubation with E2 or HDL 
decreased cytotoxicity to baseline apoptosis in endothelial cells. Recently published 
data showed, that HDL diminishes the uptake of LDL or minimally modified LDL by 
downregulation of receptors CD36 and Fc&I [Carvalho, 2010]. HDL and estrogen 
were described to impair oxidative stress and to inhibit the effect of modified LDL on 
endothelium in vasculature. 
 
By the experiments described, we wanted to discover the insights into the molecular 
mechanism of endothelial injury due to modified LDL and the role of LDLR family 
members as LDLR, LRP1, and LRP2.  
The expression levels of the LDL receptor family members such as LDLR, LRP1 and 
LRP2 were elucidated in HCAEC in normal and treated cells with different modified 
LDL. Furthermore the expression pattern at mRNA level of these receptors should be 
investigated under chronic shear stress. Cell culture cartidge, Fiber™module, allows 
to study endothelial cells under shear stress. Endothelial cells grow similar to the 
situation in a blood vessel and are subjected to low and high shear stress. This 
module mimics the human physiology of blood flow. 
 
LDLR 
 
The LDLR acts as endocytic receptor for recognition of cholesterol-laden lipoproteins 
in peripheral tissue, for membrane integrity, and synthesis of steroid hormones 
[Schneider, 2003, Goldstein, 2001]. The transcription is under tight control of SREBP, 
whereas sterol accumulation represses the synthesis of the LDLR. The LDLR was 
defined to be anti-atherogenic. A downregulation of the LDLR was seen in 
atherosclerotic events. 
Cell culture experiments showed that the LDL receptor mRNA level increased upon 
exposure to oxidized LDL. The reproduceability of in vitro oxidation of LDL is quite 
low. It depends on various factors, mainly on the blood donor. An increase of LDL 
retention at the endothelium was described to induce LDLR expression. In case of 
glycated and carbamylated LDL the expression increased not as dramatically as in 
oxidized LDL samples. Glycated LDL is more likely to be cleared by scavenger 
receptors on macrophages and endothelial cells and not by LDLR [Younis, 2009]. 
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The same group also revealed that glycated apoB in LDL influences the recognition 
by LDLR because of a conformational change.  
 
Interestingly, an excessive upregulation of LDLR could be demonstrated after E2 
treatment of HCAEC. LDLR responded to E2 in vasculature. Smith et al, 2004 
published the upregulation of LDLR in HepG2 cells after administration of E2. 
Treatment with E2 and modified LDL under static conditions showed a 
downregulation of LDLR mRNA expression.  
The transcription of LDLR in HCAEC incubated with native LDL under static 
conditions correlated with the transcript level under LSS. HSS raised LDL receptor 
mRNA level to a maximum. Blood flow with high velocity was already defined to be 
protective for vasculature. The effect on LDLR mRNA level after exposure to 
carbamylated LDL on HCAEC seemed to increase under LSS. LSS was defined as 
proatherogenic factor. Sites with LSS are more susceptible to atherosclerotic plaque 
progression. 
Concluding the results, LDLR seemed to be downreguated by modified LDL in 
atherosclerotic events. The impaired uptake of lipoproteins and lipid deposition in the 
arterial wall could be described because of reduced affinity of LDLR and LDLR-family 
members to modified lipoproteins. 
 
LRP1 
 
LRP1 is widely expressed in distinct tissues and different cell types, and was defined 
to be abundantly expressed in the vascular wall, such as vascular smooth muscle 
cells (VSMC) and macrophages. However, the expression of LRP1 is somewhat 
controversial, because quantitative results demonstrated no expression of LRP1 in 
HCAEC in cell culture, and also this group could not detect LRP1 protein in 
endothelial cells [Lilis, 2008]. 
Coronary pathologies can be linked to a change in LRP1 gene expression. The 
protective effect of LRP1 can be described by controlling vascular integrity and SMC 
[Lilis, 2008; Schulz, 2003]. LRP1 balances the activation of phosphatidyl-inositol-3-
kinase (PI3K), which drives the proliferation and SMC migration, seen in smLRP1 -/- 
mice, which resulted in higher susceptibility to atherosclerosis [Zhou, 2009]. The 
protein also controls the activation of PDGFR" and therefore the mitogenic action of 
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muscle cells [Boucher, 2007] and by means of LRP1 the vascular permeability is 
provided. 
LRP1 expression could be colocalized with aggregated LDL and VSMCs in 
atherosclerotic plaques [Llorente-Cortés, 2005].  
In accordance to the data [Lillis, 2008], LRP1 could not be detected on mRNA level 
under static conditions only when subjected to shear stress. Under LSS a decrease 
of LRP1 mRNA level pointed out compared to HSS. Similar to the expression level of 
LDLR, resulted also in a downregulation after treatment with modified LDL under LSS 
condition. Interestingly, in the case of glycated LDL the expression was higher in LSS 
than in HSS samples.  
The doubletreatment of HCAEC with modified LDL and E2 under static conditions 
resulted in a slightly upregulation of LRP1. LRP1 could not be detected on protein 
level because of its low expression. 
By known publications, LRP1 seemed to play an important role in smooth muscle 
cells and in atherosclerotic events, but in our study it seemed not to be as essentail 
in endothelial cells, because of low-level transcription. 
 
LRP2 
 
LRP2 is abundantly expressed in renal proximal tubule for renal filtration of vital 
substances [Christensen & Birn, 2001] and it is characterized as scavenger receptor 
for binding LDL. Another important function is the response and binding of sex 
steroids, such as estrogen bound to sex hormone binding globulin (SHBG). 
Vasculature is highly responsive to estrogen. 
LRP2 expression could be detected at low-level under different conditions. HCAEC 
seemed not to be responding to E2 in vascular endothelium. An approximately 10 
fold increase after treatment with modified LDL and E2 could be determined on 
mRNA level. The mRNA expression of LRP2 increased with glycated LDL, 
correlating with decreased LDLR mRNA.  
The transcription of LRP2 showed no alteration under chronic shear stress as HSS 
and LSS. In summary, LRP2 seemed to be at low mRNA level in endothelial cells. 
 
The protein level of all LDLR family members should be estimated under the same 
conditions. LDLR could be detected on protein level exclusively. LRP1 and LRP2 
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could not be determined by western blotting or Co-Immunoprecipitation with RAP. 
Determination of receptors on protein level remains to be elucidated under static 
conditions and under subjection to shear stress. 
 
Summarizing the data, LDLR seemed to be downregulated upon exposure to 
modified LDL in HCAEC in endothelial dysfunction, because of its reduced affinity to 
modified LDL. LRP1 and LRP2 were expressed at low mRNA levels under static 
conditions. LRP1 mRNA level increased under shear stress conditions. Because of 
low-level expression of LRP1 and LRP2, LDLR seemed to be the abundant receptor 
for the uptake of LDL in HCAEC. To conclude, receptors such as LDLR and LRP1 
participate in physiological functions and change when exposed to shear stress. 
Shear stress altered gene expression and had a fundamental influence on gene 
expression pattern of receptors. HSS protects and activates endothelium in 
vasculature, whereas LSS seemed to be proatherogenic. 
 
Based on these results, more interest should be raised on the gene expression 
pattern of different endothelial markers in stages of endothelial dysfunction. 
Performance of microarray analysis should be done to reveal the up- and 
downregulation of specific genes in HCAEC incubated with different modified LDL. 
Further, to investigate the role of estrogen and HDL under chronic shear stress. The 
change in gene regulation could cause the identification of protective molecules, 
which prevent atherosclerotic genesis. 
A second step should be to study the interaction of human coronary endothelial cells 
and vascular smooth muscle cells in cell culture cartridge, to mimic the in vivo 
situation of cell contacts between these two layers even better.  
A fundamental improvement would be to use blood from patients with diabetes or 
kidney disease. This will represent a mixture between native, oxidized, and other 
modified LDLs in vivo and add this blood to HCAEC in contact with VSMC. 
These future perspectives are expected to contribute to deeper insights in 
pathophysiology of atherosclerosis and thus to reveal atheroprotective strategies. 
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Abbreviations 
 
 
A     adenine 
APS      ammonium persulfate 
bp     base pair 
BSA     bovine serum albumin 
C     cytosine 
°C     Celsius 
Ca     calcium 
carb     carbamylated 
cDNA     complementary DNA 
C-terminal     carboxy-terminal 
ctrl     control 
Da     dalton 
dd     double deionized 
DNA     desoxyribonucleic acid 
dNTP     desoxynucleotidetriphosphate 
E2     moxistrol (estradiol) 
ECL     enhanced chemiluminescence  
EDTA     ethylenediaminetetraacetic acid 
ER     endoplasmatic reticulum 
FH     familial hypercholesterolemia 
fwd     forward 
G     guanine 
g     gram or gravity 
gly     glycated 
h     hour 
HCAEC    Human coronary artery endothelial cells 
HDL     high-density lipoprotein 
HRP     horseradish peroxidase 
HSS     high sheer stress 
kb     kilobases 
kDa     kilodalton 
l     liter 
LA-repeat    LDL receptor type A repeat 
LDL     low-density lipoprotein 
LDLR     low-density lipoprotein receptor 
LDH     lactat dehydrogenase 
LRP1     low-density lipoprotein receptor-related protein 
LSS     low sheer stress 
M     molar 
#g     microgram 
mg     milligram 
min     minute 
µl     microliter 
ml     milliliter 
mM      millimolar 
mRNA    messenger RNA 
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n     native 
nm     nanometer 
nt     nucleotides 
N-terminal     amino-terminal 
oN     over night 
OD     optical density 
ox     oxidized 
PAGE     polyacrylamide gelelectrophoresis 
PBS     phosphate-buffered-saline 
PCR     polymerase chain reaction 
qPCR     quantitative PCR 
rev     reverse 
RNA     ribonucleic acid 
Rnase    ribonuclease 
rpm     rounds per minute 
RT     room temperature 
RT-PCR    reverse transcriptase-PCR 
s     second 
SDS     sodium dodecyl sulfate 
T     thymine 
TAE     tris-acetate-EDTA 
TBS     tris-buffered-saline 
TBS-T    tris-buffered-saline + Tween 100 
TEMED    N,N,N´,N´tetramethylethylendiamine 
Tm     melting temperature 
U     unit 
UV     ultraviolet 
v     volume 
V     volt 
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